NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Molecular Imaging and Contrast Agent Database (MICAD)
MICAD is a key component of the NIH Common Fund (formerly NIH Roadmap); it is developed by the National Center for Biotechnology Information (NCBI), at the National Institutes of Health (NIH). More about MICAD »
After June 30 of 2013, new and revised chapters will no longer be uploaded to the MICAD website. However, the current chapters remain available online.
1444 agents currently listed. Latest update: June 27, 2013.
MICAD available through PubMed: MICAD chapters are now accessible through PubMed. To retrieve a list of all MICAD records, query PubMed for "Molecular Imaging and Contrast Agent Database (MICAD)"[book].
FDA Approved Contrast Agents: Download a list of FDA approved contrast agents (Latest update: January 2013).
Molecular Imaging Probes and Contrast Agents List: The MICAD staff has created the Molecular Imaging Probes and Contrast Agents List (MIP & CA List) by screening the PubMed/MedLine databases and other appropriate sources of such information. Only agents used in animal or human studies yielding in vivo data were selected for inclusion in the list. Although great care has been taken to accurately present all and only those imaging and contrast agents that fulfill the in vivo data criteria, this list is by no means considered complete. No one imaging modality has been given preference over the others and the omission of any agent(s) or the introduction of any errors in the list is purely unintentional. The MIP & CA List is subject to the same copyright and disclaimers as the rest of the MICAD content. Please read carefully the complete disclaimer information for MICAD before using the list. Download the list (Latest update: January 2013).
Contents
- About MICAD
- MRI
- 13C
- Hyperpolarized [1,4-13C2]fumarate as an imaging agent of tumor cell death in vivo
- Hyperpolarized [1-13C]dehydroascorbic acid
- Hyperpolarized [13C]-2-hydroxyethylpropionate
- Hyperpolarized 13C-labeled bicarbonate (H13CO3-) for in vivo pH measurement with 13C magnetic resonance spectroscopy
- Hyperpolarized sodium 1-[13C]pyruvate
- Hyperpolarized α-keto[1-13C]isocaproate as a 13C magnetic resonance spectroscopic agent for profiling branched chain amino acid metabolism in tumors
- 19F
- Cu
- Europium
- Fe
- Gadolinium
- (1-(2-(β-Galactopyranosyloxy)propyl)-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane) gadolinium(III)
- (Gd-chelate)2-Phe-His-Cys-Pro(OH)-Tyr(2-Cl)-Asp-Leu-Cys-His-Ile-Leu-(Gd-chelate)2
- [(Biotin-Ala-Ser-Lys-Lys-Pro-Lys-Arg-Asn-Ile-Lys-Ala)4-dendrimer]-streptavidin-[biotin-gadolinium 1,4,7-tris(carboxymethyl)-10-(2’-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-loaded apoferritin]
- 4,5-Diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,-17-bis(3,hydroxypropyl)oxy-13,20,25,26,27—pentaazapentacyclo-[20.2.1.13,6.19,11.014,19]heptacosa-3,5,8,10,12,14,16,18,20,22,24-undecaene gadolinium hydrates
- Anti-c-Met monoclonal antibody linked to biotinylated bovine serum albumin and gadolinium
- Anti-intercellular adhesion molecule 1 antibody–conjugated gadolinium diethylenetriaminepentaacetic acid
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody gadolinium-labeled micelles
- Anti-vascular endothelial growth factor polylactic acid-polyethylene glycol-poly-L-Lys/gadolinium-diethylenetriamine pentaacetic acid nanoparticles
- Avidin-gadolinium
- Biotinylated bovine serum albumin linked to gadolinium diethylenetriaminepentaacetic acid
- Dimeric Gd-tetraazacyclododecanetetraacetic acid-folate
- Evans Blue-diethylenetriamine-N,N,N”,N”-pentaacetic acid-gadolinium
- Folate-polyethylene glycol-ultrasmall superparamagnetic iron oxide nanoparticles
- Gadobenate
- Gadobutrol
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys-NH2
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1)
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Lys-polyethylene glycol-CGLIIQKNEC (CLT1)
- Gadolinium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-icosahedral closo-borane12 scaffold conjugated with Glu-{Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2}2
- Gadolinium-1,4,7,10-tetraazacyclododecane-N,N’,N’,N’”-tetraacetic-monoamide-24-cascade-polymer
- Gadolinium-1,4,7,10-tetraazacyclododecane-N',N'',N''',N''''-tetraacetic acid-Gly-Pro-D-Leu-D-Ala-NHOH
- Gadolinium-1,4,7,10-tetraazacyclododecane-N',N'',N''',N''''-tetraacetic acid-Pro-Leu-Ala-Leu-Lys-Arg-Asp-Arg
- Gadolinium 1-((11-S)-3,10-diaza-13-carboxamido-11-carboxy-2,9-dioxotridecyl)-N,N’,N”-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane
- Gadolinium-anti-neutrophil gelatinase-associated lipocalin 2 24p3 antibody-conjugated micelles
- Gadolinium-bis-5-hydroxytriptamide-diethylenetriamine pentaacetic acid
- Gadolinium-diethylenetriamine pentaacetic acid-24-cascade-polymer
- Gadolinium diethylenetriamine pentaacetic acid-Arg-Gly-Asp peptidomimetic
- Gadolinium-diethylenetriamine pentaacetic acid-carboxymethylarabinogalactan
- Gadolinium-diethylenetriamine pentaacetic acid-GKWHCTTKFPHHYCLY
- Gadolinium-Diethylenetriamine pentaacetic acid-Leu-Ile-Lys-Lys-Pro-Phe
- Gadolinium-Diethylenetriamine pentaacetic acid-poly(lactic-co-glycolic acid) microbubbles
- Gadolinium-diethylenetriamine tetraacetic acid-icosahedral closo-borane12 scaffold
- Gadolinium-Hexyl-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-progesterone
- Gadolinium-HU-308-incorporated micelles
- Gadolinium-incorporated mesoporous silica nanoparticles
- Gadolinium-labeled diethylenetriamine pentaacetic acid-CGLIIQKNEC
- Gadolinium-reconstituted high-density liproprotein-[palmitoyl-WK(palmitoyl)G(LRKLRKRLLR)2-NH2] nanoparticles
- Gadolinium-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys
- Gadolinium-tetraazacyclododecane tetraacetic acid coupled with folate via bis(aminoethyl)ethylene glycol linker
- Gadoteridol Gd-HP-DO3A
- GadoversetamideGd-DTPA-BMEA
- Gadoxetate
- Gd@C82 Fullerenol
- Gd-Diethylenetriaminepentaacetic acid-polylysyl-N-glutaryl-phosphatidyl ethanolamine-2C5 liposomes
- Gd-DOTA-anti-Aβ42-F(ab’)2-antibody fragment (putrescine)n
- Gd-DOTA-c(Cys-Arg-Gly-Asp-Cys)
- Gd-DOTA-G-NH(CH2)11CO-RSPAYYTAA-(CH2CH2O)8-R
- Gd-DTPA-Bz-poly(α,L-glutamic acid)
- Gd-DTPA-Cystine diethyl ester copolymers
- Gd-DTPA l-Cystine bisamide copolymers
- Gd-DTPA l-Cystine bisisopropyl amide copolymers
- Gd-DTPA l-Cystine bispropyl amide copolymers
- GKVLAK–(Gadolinium-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid t-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL
- Mouse anti-cMet monoclonal antibody linked to gadolinium diethylenetriamine pentaacetic acid conjugated to biotinylated bovine serum albumin
- Poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid micelle
- Polyion complex micelles of poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-dextran sulfate
- Pyridine-tetra-acetate-gadolinium(III) (PTA-Gd) conjugated to 17β-estradiol (EPTA-Gd) or tamoxifen (TPTA-Gd)
- TAMRA-IL-13-Conjugated functionalized gadolinium metallofullerene (Gd3N@C80(OH)-26(CH2CH2COOH)-16)
- Transferrin-coated gadolinium-labeled human serum albumin nanoparticles
- Tri-gadolinium nitride PEGylated-hydroxylated endohedral metallofullerene
- Trisodium-[(2-(R)-[(4,4-diphenylcyclohexyl)phosphono-oxymethyl]-diethylenetriaminepentaacetato)(aquo)gadolinium(III)Gadofosveset
- Iron oxide
- Amine-modified silica-coated polyhedral superparamagnetic iron oxide nanoparticle–labeled rabbit bone marrow–derived mesenchymal stem cells
- Anti-ligand–induced binding sites (LIBS) antibody conjugated to microparticles of iron oxide
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated superparamagnetic iron oxide nanoparticles
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated ultra-small superparamagnetic iron oxide nanoparticles
- Anti-vascular cell adhesion molecule antibody M/K-2.7 and anti-P-selectin antibody RB40.34 conjugated microparticles of iron oxide
- Anti-vascular cell adhesion molecule antibody M/K-2.7–conjugated microparticles of iron oxide
- Avidin-coated baculoviral vectors-biotinylated ultra-small superparamagnetic iron oxide nanoparticles
- Citrate-coated (184th variant) very small superparamagnetic iron oxide particles
- CLIO-(H-2Kd)-Lys-Tyr-Asp-Lys-Ala-Asp-Val-Phe-Leu
- Complement receptor type 2–conjugated superparamagnetic iron oxide nanoparticles
- Cross-linked iron oxide–transactivator transcription
- Cyclo(Arg-Gly-Asp-D-Try-Glu) conjugated to ultrasmall superparamagnetic iron oxide nanoparticles
- Doxorubicin-loaded poly(ethylene oxide)-trimellitic anhydride chloride-folate superparamagnetic iron oxide nanoparticles
- Ferumoxides
- Ferumoxsil
- Ferumoxtran
- FluidMAG iron nanoparticle-labeled mesenchymal stem cells for tracking cell homing to tumors
- Glycol chitosan/heparin-immobilized gold-deposited iron oxide nanoparticles
- H18/7 F(ab’)2 E-selectin monoclonal antibody conjugated to cross-linked iron oxide nanoparticles
- Iron oxide–ferritin nanocages
- Iron oxide nanoparticles-poly-L-lysine complex
- Lactoferrin-conjugated poly(ethylene glycol)-coated Fe3O4 nanoparticles
- Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles
- Magnetic iron microbeads coupled with HEA-125 monoclonal antibody against epithelial cell adhesion molecule
- MES-1 F(ab’)2 E-selectin monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticle
- Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles
- N-Alkyl-polyethylenimine 2 kDa–stabilized superparamagnetic iron oxide nanoparticles for MRI cell tracking
- Octreotide conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticle
- Ovarian cancer antigen 183B2 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles
- Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for labeling and tracking mesenchymal stem cells
- Polyethylene glycol–coated and folic acid–conjugated superparamagnetic iron oxide nanoparticles
- Saposin C-dioleylphosphatidylserine nanovesicles coupled with iron oxides
- Sialy Lewisx mimetic conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticles
- Sialy Lewisx mimetic conjugated to ultrasmall superparamagnetic iron oxide nanoparticles
- Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to magnetic iron oxide nanoparticles
- Superparamagnetic iron oxide nanoparticles (SPION) stabilized by alginate
- Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA aptamer-doxorubicin conjugate
- Thiol-modified poly(ethylene glycol)-conjugated gold/superparamagnetic iron oxide nanoparticles
- Trastuzumab-dextran iron oxide nanoparticles
- Trastuzumab-manganese–doped iron oxide nanoparticles
- Ultrasmall superparamagnetic iron oxide-anti-CD20 monoclonal antibody
- Ultrasmall superparamagnetic iron oxide-cyclo(Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys)
- Ultrasmall superparamagnetic iron oxide-Leu-Ile-Lys-Lys-Pro-Phe
- Ultrasmall superparamagnetic iron oxide nanoparticles conjugated with Ile-Pro-Leu-Pro-Phe-Tyr-Asn
- ZHER2:342 Affibody-polyethylene glycol-superparamagnetic iron oxide nanoparticles
- Manganese ferrite
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 murine monoclonal antibody manganese-micelles
- Manganese(II)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1)
- Vascular endothelial growth factor A isoform 121-gelonin fusion protein–conjugated manganese ferrite nanoparticles
- Nitroxide
- Nitroxide
- Tm3+
- Yb
- 13C
- Multimodal
- 111In, 68Ga
- 111In/68Ga-Labeled anti-epidermal growth factor receptor, native chemical ligation cyclized Affibody ZHER2:342min
- 111In/68Ga-Labeled DOTA-conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Asp-Phe-NH2 (cyclo-MG1), a minigastrin analog
- 111In/68Ga-Labeled DOTA conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Nle-Asp-Phe-NH2 (cyclo-MG2), a minigastrin analog
- 111In, Cy5.5
- 111In, Cy7
- 111In, CyAL5.5
- 111In and IRDye800
- 111In and IRDye 800CW
- 123I, 124I
- 124I, 125I
- 177Lu, cypate
- 64Cu, Cy5.5
- 64Cu, cypate
- 64Cu, quantum dot (QD705)
- 64Cu and Acridine
- 64Cu and IRDye800
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW
- 64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated IRDye 800CW (a near-infrared fluorescence dye) coupled to mAb7, an anti-epithelial cell adhesion molecule monoclonal antibody
- 64Cu-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody linked to near-infrared dye IRDye 800CW
- 64Cu and LRhodamine
- 64Cu and quantum dot
- 66/67/68Ga
- 67Ga, 68Ga
- 89Zr and IRDye 800CW
- 99mTc, iodine
- Alexa Fluor 680, gadolinium
- Au, gadolinium (Gd)
- Cy5.5, gadolinium (Gd)
- Cy5.5, gadolinium (Gd), gold (Au)
- Europium, perfluorocarbon
- Gadolinium, Texas Red
- Gadolinium (Gd3+), quantum dots (QDs)
- Gold nanoparticles, Cy5.5
- I (as iohexol); Gd (as gadoteridol)
- IR-783 and 111In
- Iron, GFP
- Iron oxide, 111In
- Iron oxide, 124I
- Iron oxide, Cy5.5
- Annexin V-cross-linked iron oxide-Cy5.5
- Anti-vascular cell adhesion molecule monoclonal antibody M/K-2.7 conjugated cross-linked iron oxide-Cy5.5 nanoparticles
- Cross-linked iron oxide-Cy5.5
- Cy5.5-Amino-terminal fragment of urokinase-type plasminogen activator conjugated to magnetic iron oxide nanoparticles
- Cy5.5-Arg-Arg-Arg-Arg-crosslinked iron oxide nanoparticle
- Gly-Ser-Ser-Lys-(FITC)-Gly-Gly-Gly-Cys-Arg-Gly-Asp-Cys-CLIO-Cy5.5
- Green fluorescent protein specified small interfering RNA-cross-linked iron oxide nanoparticles-Cy5.5
- IPLVVPLGGSC(Cy5.5-Cross-linked iron oxide)K(Fitc)
- Lys-Thr-Leu-Leu-Pro-Thr-Pro-cross-linked iron oxide-Cy5.5
- Survivin specified small interfering RNA-CLIO-Cy5.5
- VCAM-1 internalizing peptide-28 nanoparticles
- Iron oxide, Cy5.5, FITC
- Iron oxide, Cy7
- Iron oxides, RITC
- Iron oxides, VT680, 64Cu
- Microspheres, 166Ho
- Quantum dot, gadolinium
- 111In, 68Ga
- Optical
- 5-Carboxy-fluorescein
- A15
- Alexa Fluor 488
- Alexa Fluor 647
- Alexa Fluor 680
- Alexa 680 conjugated to bovine serum albumin
- Alexa Fluor 680-Bevacizumab
- Alexa Fluor 680-glycylglycylglycine-bombesin[7-14]NH2 peptide
- Alexa Fluor 680-NH-CO-CH2-S-CH2-Phe-Pro-Arg-CH2-prothrombin
- Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to Alexa 680
- LLP2A-biotin-streptavidin-Alexa Fluor 680
- Self-quenching Alexa fluor 680 conjugated to trastuzumab
- Alexa Fluor 700
- Alexa Fluor 750
- AOI987
- Au
- BODIPY-FL
- BODIPY TMR-X
- CellVue Maroon
- Cy5
- Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone
- Cbz-Phe-Lys(Cy5)-methyl ketone-2,6,dimethylterephthalic amide-hexyl-QSY 21
- Cy5-Glu-Pro-Asp-acyloxymethyl ketone
- Cy5-labeled aza-peptidyl Pro-Asn epoxide
- Cy5-Regioselectively addressable functionalized template-[cyclo-(RGD-d-Phe-Lys)]4 peptide
- Cy5-Tat-Glu-Pro-Asp-acyloxymethyl ketone
- L36-Cy5 anti-laminin trimerbody
- MFE23-Cy5 anti-carcinoembryonic antigen trimerbody
- Recombinant human erythropoietin coupled to near-infrared fluorescence dye Cy5.5
- Self-quenched-regioselectively addressable functionalized template-[cyclo-(RGD-d-Phe-Lys)]4 peptide-Cy5-fluorescence quencher QSY21
- Cy5.5
- 2-(1E,3E,5E)-5-3-(R)-1-(1-(R)-2-(R)-2-[2-(4-(Benzo[d]thiazol-2-ylamino)phenyl)\acetamido]-6-(E)-3-(pyridin-3-yl)acrylamido)hexanamido)-5-carboxypentanamido)cyclohexyl)-27-carbamoyl-1,9,13,21,25,33-hexaoxo-5,17-dioxa-2,8,14,20,26,32-hexa-azaheptatriacontan-37-yl)-1,1-dimethyl-6,8-disulfonato-1H-benzo[e]indol-2(3H)-ylid-ene)penta-1,3-dienyl)-3-ethyl-1,1-dimethyl-1H-ben-zo[e]indolium-6,8-disulfonate
- Chlorotoxin:Cy5.5
- Cy5.5-3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxyphenyl)-4-(3,4,5-trimethoxybenzyl)-5H-furan-2-one)
- Cy5.5-8-Amino-octanoic acid-Ser-Cys-Pro-Pro-Trp-Gln-Glu-Trp-His-Asn-Phe-Met-Pro-Phe-NH2
- Cy5.5-Ac-Cys-ZEGFR:1907
- Cy5.5-Aminohexanoic acid-RPLALWRS-aminohexanoic acid-C-G4-PAMAM-PEG-AF750
- Cy5.5-Annexin V
- Cy5.5-Anti-ephrin receptor B4 (EphB4) humanized monoclonal antibody hAb47
- Cy5.5-Asp-Gly-Glu-Ala (DGEA)
- Cy5.5-Asp-Gly-Glu-Ala-Gly-Lys-(Arg)8-OH
- Cy5.5-c(Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp)NH2
- Cy5.5-CGRRRQRRKKRG-Labeled T lymphocytes
- Cy5.5-Chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101
- Cy5.5 conjugated anti-epidermal growth factor receptor monoclonal antibody
- Cy5.5-Conjugated anti-epidermal growth factor receptor monoclonal antibody C225
- Cy5.5-Conjugated anti-human CD31 monoclonal antibody
- Cy5.5-Conjugated glycol chitosan-5β-cholanic acid nanoparticles
- Cy5.5-Conjugated matrix metalloproteinase cleavable peptide nanoprobe
- Cy5.5-Cyclo(CGNSNPKSC)
- Cy5.5-Endostatin
- Cy5.5-Epidermal growth factor
- Cy5.5-Ferritin nanocages
- Cy5.5-GGPRQITAGK(Fitc)C-Poly-L-lysine-methoxypolyethylene glycol
- Cy5.5-GGSGRSANAK(Fitc)C-poly-L-lysine-methoxy polyethylene glycol
- Cy5.5-Gly-His-Pro-Gly-Gly-Pro-Gln-Gly-Lys(Fitc)-Cys-Poly-L-lysine-methoxypolyethylene glycol
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-(TDOPA)3-flower-like gold–Fe3O4 optical nanoparticles
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-Ferritin-black hole quencher-3 nanocages
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-gold nanoparticles
- Cy5.5-Human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein
- Cy5.5-Knottin 2.5D
- Cy5.5-Knottin 2.5F
- Cy5.5-labeled pH low insertion peptide (pHLIP)
- Cy5.5-Polyethylene glycol-CGS25966 inhibitor of matrix metalloproteinases
- Cy5.5-Poly-L-lysine-methoxypolyethylene glycol
- Cy5.5-Rituximab
- Cy5.5-Single-chain Cys-tagged vascular endothelial growth factor-121
- Cy5.5-Trastuzumab
- Cyclo(Arg-Gly-Asp-d-Tyr-Lys)-Cy5.5
- Cyclo(Cys-Arg-Gly-Asp-Cys)-Gly-Lys-Cy5.5
- Cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-Cy5.5
- Cys-Arg-Lys-Arg-Leu-Asp-Arg-Asn-Cys-glycol chitosan-Cy5.5 nanoparticles
- D-Cys-D-Asp-Gly-HCit-Gly-Pro-Gln-D-Cys-Ebes-Ebes-Lys-Cy5.5
- D-Cys-D-Asp-Gly-HCit-Gly-Pro-Gln-D-Cys-Ebes-Lys-polyethylene glycol-cholic acids-Cy5.5 telodendrimer nanoparticles
- D-Cys-D-Asp-Gly-Leu-Gly-ProOH-Asn-D-Cys-biotin-streptavidin-Cy5.5
- D-Cys-D-Asp-Gly-Tyr(3-NO2)-Gly-ProOH-Asn-D-Cys-biotin-streptavidin-Cy5.5
- Fibroblast activation protein α–specific, near-infrared peptide probe (KGPGPNQC) linked to Cy5.5 and a quencher dye, QSY21
- Mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid conjugated to Cy5.5
- Mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly conjugated to Cy5.5
- Sialyl-Lewisx-liposome-Cy5.5
- Cy7
- Cypate
- DiD
- DiR
- DY675
- DY682
- DY750
- Fluorescein
- Fluorescein isothiocyanate (FITC)
- Green fluorescence protein
- Green fluorescence protein (GFP), luciferin
- HiLyte Fluor 647
- IANBD
- Indocyanine green
- Anti-human sperm protein 17 monoclonal antibody-indocyanine green derivative 02
- Bovine serum albumin–stabilized gold nanoclusters conjugated with folate and indocyanine green derivative 02
- Bovine serum albumin–stabilized gold nanoclusters conjugated with l-methionine and indocyanine green derivative 02
- Daclizumab complexed to near-infrared fluorophore indocyanine green
- Folic acid-indocyanine green-poly(d,l-lactide-coglycolide)-lipid nanoparticles
- Indocyanine green derivative 02-2-deoxy-d-glucose
- Indocyanine green derivative 02-Glu-c(RGDyK)2
- Indocyanine green–doped calcium phosphate nanoparticles
- Indocyanine green-polyethylene glycol-folate
- l-Methyl-methionine-indocyanine green derivative 02
- Quenched indocyanine green-anti-prostate-specific membrane antigen antibody J591
- Trastuzumab complexed to near-infrared fluorophore indocyanine green
- Indocyanine green and Alexa Fluor680
- IR-783
- IR-786
- IR-820
- IR-820 and FITC
- IRDye700DX
- IRDye78
- IRDye 800CW
- Biotinylated vascular endothelial growth factor121-Avi-streptavidin-IRDye800
- Humanized anti-CD44v6 monoclonal antibody labeled with IRDye800CW
- IRDye800-2-(3-{5-[7-(5-amino-1-carboxy-pentylcarbamoyl)-heptanoylamino]-1-carboxy-pentyl}-ureido)-pentanedioic acid
- IRDye800-2-Deoxy-D-glucose
- IRDye 800-albumin-binding domain-fused-ZHER2:342 Affibody
- IRDye 800-Anti–epidermal growth factor receptor Affibody
- IRDye800-Anti-vascular endothelial growth factor receptor-2 monoclonal antibody Avas12a1
- IRDye800CW-anti-CD105 TRC105 chimeric monoclonal antibody
- IRDye 800CW-Anti-epidermal growth factor receptor nanobody 7D12
- IRDye800CW-Cyclic albumin-binding domain (Ac-RLIEDICLPRWGCLWEDDK-NH2)
- IRDye 800CW-Epidermal growth factor
- IRDye 800CW-Human serum albumin
- Near-infrared Dye®800CW–conjugated disulfide-based cyclic RGD peptide c(CRGDKGPDC) and its DOTA analog
- Near-infrared dye IRDye 800CW-labeled butyrylcholinesterase
- IRIS Blue
- Luciferin
- Malachite green
- NIAD-4
- NIR2
- Oregon Green 488
- Pyropheophorbide α (Pyro)
- Quantum dot (QD)
- Anti-α-Fetoprotein antibody-quantum dots
- Arginine-glycine-aspartic acid peptide-labeled quantum dot 705
- Epidermal growth factor conjugated to near-infrared fluorescent quantum dots
- Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to cadmium telluride quantum dots
- Ligand-conjugated, gold-doped CdHgTe quantum dots for multispectral imaging
- QD800-Anti-epidermal growth factor receptor monoclonal antibody nanoparticles
- QD800-Polyethylene glycol-Cys-ZHER2:342 Affibody
- Quantum dot 800-conjugated anti-Tn IgM 2154F12A4 murine monoclonal antibody
- Quantum dot 800–mercaptopropionic acid
- Quantum dot800-poly(ethylene glycol)-c(Arg-Gly-Asp-d-Tyr-Lys)
- Quantum dot 800–prostate-specific membrane antigen antibody J591
- Quantum dot-A10 RNA aptamer-doxorubicin conjugate
- Quantum dot-prostate-specific membrane antigen antibody J591
- Quantum dots-deoxycholic acid (DOCA)-conjugated low molecular weight heparin (LMWH) nanoparticles
- Quantum dot-trastuzumab
- Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to functionalized quantum dots
- Rhodamine green (RhodG)
- RhodamineX
- SIDAG
- Single-walled carbon nanotubes (SWNTs)
- Tetramethyl-6-carboxyrhodamine
- Tetramethylrhodamine
- THK-265
- TOTO-3
- VivoTag 750
- VivoTag-S680
- VM315
- ZW800-1
- PET
- 11C
- (-)-3-(4-Chlorophenyl)-N'-[(4-[11C]cyanophenyl)sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine
- (-)-4-[11C]Methoxycarbonyl-2-[(1-pyrrolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl]-piperidine
- (-)-N-[11C]Propyl-norapomorphine
- (+/-)-2-(N-Cyclohexylethyl-N-[11C]propyl)amino-5-hydroxytetralin
- (+/-)-2-(N-Phenethyl-N-1'-[11C]propyl)amino-5-hydroxytetralin
- (+)-(2S,3S)-3-(2-[11C]Methoxybenzylamino)-2-phenylpiperidine
- (+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-[11C]methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
- (+)-p-[11C]Methylvesamicolphenoxy)
- (1R,2R)-N-(3-(4-[11C]Methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropane-carboxamide
- (20R)-4,5-α-Epoxy-17-methyl-3-hydroxy-6-[11C]methoxy-α,17-dimethyl-α-(2-phenylethyl)-6,14-ethenomorphinan-7-methanol
- (2-methoxy-11C)-N-(4-(3,4-Dihydro-6,7-dimethoxy-isoquinolin-2(1H)-yl)butyl)-5-methylbenzamide
- (2S,3S)-(2-[11C]Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine
- (2S,3S)-2-[α-(2-[11C]Methylphenoxy)phenylmethyl]morpholine
- (2S,3S)-N-[[2-[11C]Methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenyl-piperidin-3-amine
- (3-Ethyl-2-[11C]methyl-6-quinolinyl)(cis-4-methoxycyclohexyl)methanone
- (3R,5R)-3-((R)-1-(4-Fluorophenyl)ethylamino)-5-(3-[11C]methoxyphenyl)-1-(4-trifluoromethylphenyl)pyrrolidin-2-one
- (3R,5R)-5-(3-[11C]Methoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (R,S)-1,2,3,4,10,14b-Hexahydro-2-[11C]methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
- (R,S)-2-(N-Propyl-N-1'-[11C]-propyl)amino-5-hydroxytetralin
- (R)-(-)-2-Chloro-N-[1-11C-propyl]n-propylnorapomorphine
- (R)-(+)-8-Chloro-2,3,4,5-tetrahydro-3-[11C]methyl-5-phenyl-1H-3-benzazepin-7-ol ([11C]SCH 23390)
- (R)-2,3,4,5,6,7-Hexahydro-1-[4-[1-[4-(2-[11C]methoxyphenyl)piperazinyl]]-2-phenylbutyryl]-1H-azepine
- (R)-2-[11C]Methoxy-N-n-propylnorapomorphine
- (S,S)-[11C]Methylreboxetine
- (S)-1-(4–2-[11C]Methoxybenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- (S)-5-Methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl]-oxazolidin-2-[11C]one
- (S)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-[11C]methyl-1H-benzotriazole
- (S)-N-(1-Ethyl-2-pyrrolidinyl)methyl)-5-bromo-2-[11C]methoxy-3-methoxybenzamide
- [11C](+)-4-N-Propyl-,3,4a,5,6,10b-hexahydro-2H-naphth[1,2-b][1,4]-oxazin-9-ol
- [11C](5R)-5-(Methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-2-oxazolidinone
- [11C]-[N-Methyl]3-[(3-fluorophenyl)sulfonyl]-8-(4-methyl-1-piperazinyl)quinoline
- [11C]10-Methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline
- [11C]2-(2-((Dimethylamino)methyl)phenylthio)-5-(2-fluoroethyl)phenylamine
- [11C]2-(2-(Dimethylaminomethyl)phenylthio)-5-fluoromethylphenylamine
- [11C]2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole
- [11C]2-(Dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2-yl)acetamide
- [11C]2-2-(Dimethylaminomethyl)phenylthio)-5-fluorophenylamine
- [11C]4-N-Methylamino-4´-hydroxystilbene
- [11C]5-Hydroxy-2-(4-methyaminophenyl)benzofuran
- [11C]Acetate
- [11C]Acetoacetate
- [11C]Carfentanil
- [11C]Choline
- [11C]Glycylsarcosine
- [11C]meta-Hydroxyephedrine
- [11C]Methylated LY2181308
- [11C]N,N-Dimethyl-2-(2´-amino-4´-hydroxymethylphenylthio)benzylamine
- [11C]N,N-Dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine
- [11C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
- [11C]N-Methyl-N-phenyl-[2-(4-chlorophenyl)-6,8-dichloroimidazo[1,2-a]pyridin-3-yl]acetamide
- [11C]Norepinephrine
- [11C]-p-Hydroxyphenethylguanidine
- [11C]Triphenylmethylphosphonium
- [18F]-3-Fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
- [1-methyl-11C]8-Dicyclopropylmethyl-1-methyl-3-propylxanthine
- [4-O-methyl-11C]-8-[(E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione
- [6-O-methyl-11C]Diprenorphine
- [7-methyl-11C]-(E)-8-(3,4,5-Trimethoxystyryl)-1,3,7-trimethylxanthine
- [carbonyl-11C](R,S)-(N-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)(2-methylethyl)))-N-pyridinyl)cyclohexanecarboxamide
- [Carbonyl-11C](S)-3-chloro-4-(4-((2-(pyridine-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide
- [Carbonyl-11C]N-(2-(1-(4-(2-Methoxyphenyl)-piperazinyl)ethyl)-N-pyridinyl)cyclohexanecarboxamide
- [Carbonyl-11C]-N-(4-Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide
- [N-11C-methyl]-[4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide
- [N-Methyl-11C]-(11β17α)-11-[4-(dimethylamino)phenyl]-17-hydroxy-21-[4-(methylsulfonyl)phenyl]-19-norpregna-4,9-dien-20-yn-3-one
- [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-dimethyl-butanamide
- [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-methyl-butanamide
- [O-11C-methyl]4-N-(3-Bromoanilino)-6,7-dimethoxyquinazoline
- [O-methyl-11C]2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione
- [O-methyl-11C]2-{4-[4-(7-Methoxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione
- [S-methyl-11C]N,N-Dimethyl-4-(6-(methylthio)imidazo[1,2-a]pyridine-2-yl)aniline
- 1-([4-methoxy-11C]-3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazinephenoxy)
- 1-([4-methoxy-11C]3,4-Dimethoxyphenethyl)-4-[3-(4-fluorophenyl)propyl]piperazine
- 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid [11C]methyl ester
- 1-(2,4-Dichlorophenyl)-4-cyano-5-(4-[11C]methoxyphenyl)-N-(pyrrolidin-1-yl)-1H-pyrazole-3-carboxamide
- 1-(2-Chlorophenyl)-N-[11C]methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide
- 1-(3,4-[11C]Dimethoxyphenethyl)-4-[3-(3,4-dichlorophenyl)propyl]piperazinephenoxy)
- 1-(3-[11C]Methoxy-4-methoxybenzyl)-6,7-dimethoxyisoquinoline
- 1-(9H-Carbazol-4-yloxy)-3-(2-(2-[11C]methoxyphenoxy)ethylamino)-propan-2-ol
- 1-(Benzofuran-2-ylmethyl)-4-(4-[11C]methoxybenzyl)piperazine
- 1-[11C]Arachidonic acid
- 1-[11C]Methylpiperidin-4-yl propionate
- 1-11C-Methyl-4-piperidinyl n-butyrate
- 11C/68Ga-Labeled sel-tagged anti-epidermal growth factor receptor 2 affibody ZHER2:342
- 11C-Labeled 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
- 11C-Labeled 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride
- 11C-Labeled GSK931145
- 11C-Labeled isoniazid
- 11C-Labeled pyrazinamide
- 11C-Labeled rhodamine-123
- 11C-Labeled rifampicin
- 11C-Labeled Telmisartan, an angiotensin II type 1 receptor antagonist
- 1R-[11C]Phenylephrine
- 2,2,3,3-Tetramethylcyclopropanecarboxylic acid [3-(2-[11C]methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide
- 2-(2-(3-[11C]Methoxyphenyl)ethynyl)pyridine
- 2-(2-(5-[11C]Methoxypyridin-3-yl)ethynyl)pyridine
- 2-(2-[[O-11C]Tolyl)vinyl]-4,5-dihydro-1H-imidazole
- 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-[11C]methyl-amino]-2-propan-2-yl-pentanenitrile
- 2-(3-Fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole
- 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine
- 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine
- 2-(5-[11C]Methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthene-9-one
- 2-(6-[11C]Methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-9H-fluoren-9-one
- 2-[11C]Methyl-5-[6-phenylpyridazine-3-yl]octahydropyrrolo[3,4-c]pyrrole
- 2-[11C]Methyl-6-(2-phenylethynyl)pyridine
- 2-[2-([O-11C]Tolyl)ethyl]-4,5-dihydro-1H-imidazole
- 2-[methyl-11C]Methoxyestradiol
- 2-Butyl-5-[11C]methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine
- 2-chloro-N-((S)-((S)-1-[11C]methylpiperidine-2-yl)(thiophen-3-yl)methyl)-3-(trifluoromethyl)benzamide ([11C]SA1) and derivatives
- 2-Hydroxy-3-isobutyl-9-[11C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine
- 2β-Carbo[11C]methoxy-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2β-Carbo[11C]methoxy-3β-(4´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2’-Fluoro-5-([11C]-methyl)-1-β-D-arabinofuranosyluracil
- 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime
- 3-[3,5-Dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide
- 3-Fluoromethyl-N-[11C]methyl-4-phenyl-N-(phenylmethyl)quinoline-2-carboxamide
- 3-N-[11C]Methylspiperone
- 4-(3-Cyclopentoxy-4-[11C]methoxy-phenyl)pyrrolidin-2-one
- 4-[11C]Methylphenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate
- 4-Acetoxy-7-chloro-3-(3-(-4-[11C]methoxybenzyl)phenyl)-2(1H)-quinolone
- 4-Cyano-1-(2,4-dichlorophenyl)-5-(4-[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
- 4-Hydroxy-, 5-hydroxy-, and 7-hydroxy- analogs of 6-hydroxy-2-(4’-[11C]methylaminophenyl)-1,3-benzothiazole
- 5-(6-(5-[11C]methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole
- 5-Amino-7-(3-(4-[11C]methoxy)phenylpropyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
- 5-Methyl-8-(4-[11C]methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)-amide
- 6,7-Dimethoxy-2-[3-(5-[11C]methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-1,2,3,4-tetrahydro-isoquinoline
- 6,7-Dimethoxy-2-{3-[4-[11C]methoxy-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-propyl}-1,2,3,4-tetrahydro-isoquinoline
- 6-Hydroxy-[1,1'-biphenyl]-3-yl-cyclohexyl-[11C-carbonyl]carbamate
- 7-[ 11C]Methoxy-1-methyl-9H-[3,4-b]indole
- 8-((E)-4-Fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid [11C]methyl ester
- Biphenyl-3-yl-4-[11C]methoxyphenylcarbamate
- Dimethylamino-3(4-[11C]methoxyphenyl)-3H-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-one
- Ethyl 8-fluoro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
- L-[5-11C]-Glutamine
- l-[methyl-11C]Methionine
- Methyl-[11C]-4'-thiothymidine
- N,N-Diethyl-2-2(2-(4-[11C]methoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide
- N-(2-[11C],5-Dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide
- N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-4-[11C]methoxy-N-methylbenzamide
- N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-N-methyl-4-[11C]methylbenzamide
- N-[(1s)-1-[4-[[4-methoxy-2-[(4-[11C]methoxyphenyl)sulfonyl]-phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide
- N-[[4'-[(2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine-3-yl)methyl][1,1'-biphenyl]-2-yl]sul-fonyl]-4-[11C]methoxybenzamide
- N-[11C]Methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2’,2’-diphenylpropionoxymethyl)pyridinium
- N-[11C]Methylpiperidin-4-yl acetate
- N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-[11C]methoxybenzamide
- N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine
- N1’-([11C]Methyl)naltrindole
- N2-{6-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]hexyl}-N2-[11C]methyl-2-furamide
- N-4-Fluorobut-2-yn-1-yl-2β-carbo-[11C]methoxy-3β-phenyltropane
- N-Acetyl-N-(2-[11C]methoxybenzyl)-2-phenoxy-5-pyridinamine
- N-Benzyl-N-ethyl -2-(7-[11C]-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide
- N-Methyl-[11C]-2-(4'-methylaminophenyl)-6-hydroxybenzothiasole
- O-[11C]methyl derivative of 6,7-dimethoxy-2-(4-methoxy-biphenyl-4-yl-methyl)-1,2,3,4-tetrahydro-isoquinoline
- R-(−)-[11C]Epinephrine
- S-[11C]Methyl-L-cysteine
- S-4-(3-([11C]Isopropylamino)-2-hydroxypropoxy)-2H-benzimidazol-2-one
- trans-(+)-1,2,3,5,6,10b-Hexahydro-6-(4-([11C]methylthio)-phenyl)pyrrolo-(2,1-a)-isoquinoline
- 124I
- [124I]Iodo-azomycin-galactoside
- 124/131I-Labeled apoptosis-targeting peptide-1 (ApoPep-1)
- 124I/64Cu-Labeled anti-CD20 minibody
- 124I-Annexin V
- 124I-Anti-CD44v6 chimeric monoclonal antibody U36
- 124I-Anti–prostate stem-cell antigen back-mutated 2B3 diabody
- 124I-Anti-PSCA 2B3 minibody
- 124I-Chimeric monoclonal antibody G250
- 124I-Labeled antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1)
- 124I-Labeled anti-CD20 scFv-sc fragment
- 124I-Labeled anti-HER2-specific C6.5 diabody
- 124I-Labeled anti-prostate stem cell antigen affinity-matured A11 minibody
- 124I-Labeled humanized CH2-domain-deleted anti-tumor-associated glycoprotein-72 (TAG-72) monoclonal antibody
- 124I-Labeled residulizing ligand IMP-R4 conjugated chimeric monoclonal antibody ch806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 2'-Fluoro-2'-deoxy-5'-[123/124/125/131I]iodo-1β-d-arabinofuranosyluracil
- 13N
- 149Tb, 152Tb, 155Tb, 161Tb
- 18F
- (-)-7-Methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane
- (+)-2-Hydroxy-3-isobutyl-9-(3-[18F]fluoropropoxy)-10-methoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine
- (1R,2S,3S,5S)-Methyl-8-{[(1S,2S)-2-([18F]fluoromethyl)cyclopropyl]methyl}-3-phenyl-8-azabicyclo[3.2.1]octane-2-carboxylate
- (20R)-4,5-α-Epoxy-6-(2-[18F])fluoroethoxy)-3-hydroxy-α,17-dimethyl-α-(2-phenyleth-1-yl)-6,14-ethenomorphinan-7-methanol
- (3R,5R)-5-(3-(2-[18F]Fluoroethoxy)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (3R,5R)-5-(3-[18F]Fluoromethoxy-d2)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (3R,5R)-5-(3-[18F]Fluoromethoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (4S)-4-(3-[18F]Fluoropropyl)-l-glutamate
- (E)-2-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)-5-(4-dimethylaminostyryl)-pyridine
- (E)-3-(4-(Dimethylamino)phenyl)-1-(4-(2-(([18F]fluoroethoxy)ethoxy)ethoxy)phenyl)-2-propen-1-one
- (E)-3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-O-2-(2-[18F]fluoroethoxy)ethyl oxime
- (E)-4-(2-(6-(2-(2-(2-([18F]-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine
- (R,S)-2-(N-Propyl-N-5'-[18F]fluoropentyl)amino-5-hydroxytetralin
- (R,S)-anti-1-Amino-2-[18F]fluorocyclopentyl-1-carboxylic acid
- (R)-2-(N-Benzyl-4-(2-[18F]fluoroethoxy)phenylsulfonamido)-N-hydroxy-3-methylbutanamide
- (R)-2-Amino-3-[18F]fluoro-2-methylpropanoic acid
- (R)-3-[18F]Fluoro-2-methyl-2-N-(methylamino)propanoic acid
- (S,S)-2-(α-(2-[18F]Fluoro[2H2]methoxyphenoxy)phenoxy)benzyl)morpholine
- (S,S)-2-[α-(2-(2-[18F]Fluoro[2H4]ethoxy)phenoxy)benzyl]morpholine
- (S,S)-2-[α-(2-(2-[18F]Fluoroethoxy)phenoxy)benzyl]morpholine
- (S)-1-((1-(2-[18F]Fluoroethyl)-1H-[1,2,3]-triazol-4-yl)methyl)-5-(2-4-difluorophenoxymethyl-pyrrolidine-1-sulfonyl)isatin
- (S)-1-(4-(2-[18F]Fluoroethoxy)benzyl)-5-[1-(2-methoxymethyl-pyrrolidinyl)sulfonyl]-1H-indole-2,3-dione
- (S)-2-Amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid
- (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide
- (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2-methoxybenzamide
- [18F]1-(2-Fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine
- [18F]1-(3-Fluoropropyl)-4-[(4-cyanophenoxy)methyl]piperidine
- [18F]-2-(2-Nitroimidazol-1H-yl)-(3,3,3-trifluoropropyl)acetamide
- [18F]3-(1H-Imidazol-4-yl)propyl-4-fluorobenzyl ether
- [18F]3-Fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile
- [18F]3-Fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile
- [18F]-5-(2-fluoroethyl)2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate
- [18F]5-(6-Fluorohexyn-1-yl)-3-[2(S)-2-azetidinylmethoxy]pyridine
- [18F]6-(2-Fluoropropyl)-4-methyl-pyridin-2-amine
- [18F]6-fluoro-3-O-methyl-L-3,4-dihydroxyphenylalanine
- [18F]FB-(Ac-NIe-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2)
- [18F]FB-NH-mini-PEG-E{E[c(RGDyK)]2}2
- [18F]Fluoro-[1,2-2H4]choline
- [18F]Fluoro-2-deoxy-2-D-glucose
- [18F]-Fluoro-2-deoxy-d-glucose-folate
- [18F]Fluorobenzaldehyde-leptin
- [18F]Fluorobenzoyl-((VHPKQHRGGSY)2K)2KK
- [18F]Fluorobenzoyl anti-HER2 Cys-diabody
- [18F]Fluorobenzoyl-PEGylated cyclic arginine-glycine-aspartic acid peptide
- [18F]Fluorobenzyl-bombesin[7-14]-c(RGDyK)
- [18F]Fluorobenzyl-PEG3-Glu-c(RGDyK)-bombesin[7-14]
- [18F]Fluorocholine
- [18F]Fluorodipalmitin-labeled liposomes
- [18F]Fluoroerythronitroimidazole
- [18F]Fluoroetanidazole
- [18F]Fluoroethylcholine
- [18F]Fluoroethyl-recombinant human interlukin-1 receptor antagonist
- [18F]Fluoromethyl-d-tyrosine
- [18F]Fluoromisonidazole
- [18F]Fluoropropyl-Tanaproget
- [18F]-Labeled (R)-(2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(4-fluorophenyl)-methanone
- [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine
- [18F]-N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
- [18F]-N-{4-[(4,5-Dichloro-2-fluorophenyl)amino]quinazoline-6-yl}-dimethylamine-butylamide
- [18F]Norchloro-fluoro-homoepibatidine
- [18F]SB209670
- [18F]Y1-973
- [18F]α/γ-Fluorobenzylamine-folate
- [2-[18F]Fluoromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]([2S,3S]2-phenyl-piperidin-3-yl)-amine
- 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-4-((6-[18F]fluoropyridin-3-yl)methyl)piperazine
- 1-(2'-Deoxy-2'-[18F]fluoroarabinofuranosyl)cytosine
- 1-(2'-Deoxy-2'-[18F]fluoro-β-d-arabinofuranosyl)-5-iodocytosine
- 1-(2-[18F]Fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole
- 1-(2-[18F]Fluoro-3-pyridyl)-4-(2-propyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole
- 1-(2-{(2R)-1-[(2-[18F]Fluorophenyl)sulfonyl]pyrrolidin-2-yl}ethyl)-4-methylpiperidine
- 1-(2’-Deoxy-2’-[18F]-fluoro-β-D-arabinofuranosyl)thymine
- 1-(4-[18F]Fluoroethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine
- 1-(4-[18F]Fluoromethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine
- 1-(5-[18F]Fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole
- 1-[18F]Fluoro-3,6-dioxatetracosane
- 1-[4-(2-[18F]Fluoroethoxy)-benzyl]-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[4-(3-[18F]Fluoropropoxy)-3-methoxyphenyl]-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one
- 11C-BMS-5p and 18F-FBzBMS: radiolabeled analogs of BMS-207940, a potent and selective antagonist of endothelin receptor subtype A
- 16α-[18F]Fluoro-17β-estradiol
- 18-[18F]Fluoro-4-thia-oleate
- 18-[18F]Fluoro-4-thia-palmitate
- 18F-(2S,4R)4-fluoroglutamine
- 18F-1,4,7-Triazacyclononane-1,4,7-triacetic acid-10-maleimidoethylacetamide-Affibody ZHER2:2395
- 18F-6-Fluoro-N-[2-(diethylamino)ethyl]pyridine-3-carboxamide
- 18F-Fluoroethyl triazole-βAG-[(d)-Phe1-c(Cys2-Tyr3-(d)-Trp4-Lys5-Thr6-Cys7)Thr8]
- 18F-Labeled 4-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N,N-dimethylbenzenamine
- 18F-Labeled 5-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N,N-dimethylpyridin-2-amine
- 18F-Labeled 6-amino-2-(4’-fluorophenyl)-1,3-benzothiazole and other derivatives
- 18F-Labeled 6-methyl-2-(4’-fluorophenyl)-1,3-benzothiazole
- 18F-Labeled Cys-ZHER2:342, an anti-epidermal growth factor receptor-2 Affibody
- 18F-Labeled exendin(9-39)
- 18F-Labeled fluoropegylated 6-fluoroethoxy-4'-dimethylaminoflavone, 6-(2-(2-fluoro-ethoxy)-ethoxy)-4'-dimethylaminoflavone, and 6-(2-(2-(2-fluoro-ethoxy)-ethoxy)ethoxy)-4'-dimethylaminoflavone
- 18F-Labeled N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-iodo-3-methoxybenzamide
- 18F-Labeled N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-fluoroethoxy)-5-methylbenzamide
- 18F-Labeled N-(4-fluorobenzylidene)oxime-dimeric (ZHER2:477)2
- 18F-Labeled N-(4-fluorobenzylidene)oxime-monomeric ZHER2:477
- 18F-Labeled N-(4-fluorobenzylidene)oxime-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 18F-Labeled neogalactosylalbumin
- 18F-Labeled N-succinimidyl-4-fluorobenzoate–conjugated rat anti-mouse vascular endothelial growth factor receptor 2 monoclonal antibody linked to microbubbles
- 18F-Labeled poly(L-lactic acid)-block-poly(sarcosine) lactosome, a polymer micelle
- 18F-Tetrazine-trans-cyclooctene-Cys40-exendin-4
- 1-Deoxy-1-[18F]fluoro-scyllo-inositol
- 1-O-(4-(2-[18F]Fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-d-glucopyronuronate
- 2´-Deoxy-2´-[18F]fluoro-5-fluoro-1-β-D-arabinofuranosyluracil
- 2'-Deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl-adenine
- 2-((2-Amino-4-chloro-5-[18F]fluorophenyl)thio)-N,N-dimethylbenzenmethanamine
- 2-(+/-)-2-exo-(2'-[18F]Fluoro-3'-phenyl-pyridin-5'-yl)-7-azabicyclo[2.2.1]heptane
- 2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile
- 2-(2'-((Dimethylamino)methyl)-4'-(3-[18F]fluoropropoxy)-phenylthio)benzenamine
- 2-(2-(2-(4-((4-(Methylamino)phenyl)ethynyl)phenoxy)ethoxy)[18F]fluoroethoxy)ethyl-4-methylbenzenamine
- 2-(2-Nitro-1H-imidazol-1-yl)ethyl 2-[18F]fluoroacetate
- 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[18F]pentafluoropropyl)-acetamide
- 2-(2-Nitroimidazol-1H-yl)-(3-[18F]fluoropropyl)acetamide
- 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid
- 2-(4-(2-[18F]Fluoroethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine
- 2-(4-(4-[18F]Fluoro-butyl)-benzylsulfanyl)-3-methyl-chromen-4-one
- 2-(4-Aminophenyl)-6-(2-([18F]fluoroethoxy))quinoline
- 2-(5-[18F]Fluoro-pentyl)-2-methyl-malonic acid (ML-10)
- 2-(6-Chloro-2-(4-(3-[18F]fluoropropoxy)phenyl)imidazo[1,2-a]pyridin-3-yl)-N,N-diethylacetamide
- 2-[(2-chloro-2’-18F-fluorodiethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide
- 2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(2-[18F]-fluoro(4-pyridyl))carbonylamino] carbamoyl}butanoic acid
- 2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(4-[18F]-fluorophenyl)carbonylamino] carbamoyl}butanoic acid
- 2-[18F]Fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine
- 2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine
- 2-[18F]Fluoroacetate
- 2-[18F]Fluoro-N-(2-(2-nitro-1H-imidazol-1-yl)ethyl)acetamide
- 2-[18F]Fluoropropionyl-osteosarcoma–specific peptide-1 (ASGALSPSRLDT)
- 2-[18F]Fluoropyridine-4-carbohydrazide-methotrexate
- 2-[4-(4-[18F]Fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one
- 2-{3-[18F]Fluoro-4-(methylamino)phenyl}-1,3-benzothiazol-6-ol
- 2-{4-[-Pyridin-4-yl-1-(2-[18F]fluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline
- 2-Deoxy-2-[18F]fluorosorbitol
- 2-tert-Butyl-4-chloro-5-[4-(2-[18F]fluoroethoxymethyl)-benzyloxy]-2H-pyridazin-3-one
- 2-tert-Butyl-4-chloro-5-[4-(2-[18F]fluoro-ethoxymethyl)-benzyloxy]-3-(2H)-pyridazinone
- 2-tert-Butyl-4-chloro-5-[4-(4-[18F]fluoro-butyl)-benzyloxy]-2H-pyridazin-3-one
- 2β-Carbo(2-[18F]fluoroethoxy)-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2β-Carbo(2-[18F]fluoroethoxy)-3β-(4´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-[18F]fluoroethyl)nortropane
- 2’-[18F]Fluoroflumazenil
- 2’-[18F]Fluorofolic acid
- 3'-Aza-2'-[18F]fluorofolic acid
- 3'-Deoxy-3'-[18F]fluoro-1-β-D-xylofuranosyl-adenine
- 3'-Deoxy-3'-[18F]fluorothymidine
- 3-(2-(S)-3,4-Dehydropyrrolinyl methoxy)-5-(3'-[18F]fluoropropyl)pyridine
- 3-(3-(3-[18F]Flouropropyl)thio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine
- 3-(4-[18F]Fluorobenzyl)-8-methoxy-1,2,3,4 tetrahydrochromeno[3,4-c]pyridin-5-one
- 3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-O-[18F]fluoroethyl-oxime
- 3-[2-[4-(4-[18F]Fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one
- 3-{4-[2-[Benzoxazol-2-yl-methylamino]ethoxy]phenyl}-2-(2-[18F]fluoroethoxy)propionic acid
- 3-Chloro-4-[18F]fluorophenyl-(4-fluoro-4-[[((5-methyl-4-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F13714)
- 3-Chloro-4-[18F]fluorophenyl-(4-fluoro-4-[[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F15599)
- 3-Cyano-4-[18F]fluoro-benzoyl-Ala(SO3H)-Ala(SO3H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2
- 3-Cyano-4-[18F]fluoro-benzoyl-Ala(SO3H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2
- 3-Cyano-4-[18F]fluoro-benzoyl-Arg-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2
- 3-N-(2-[18F]Fluoroethyl)spiperone
- 3-β-(4-Iodophenyl)tropane-2-β-carboxylic acid 2-[18F]fluoroethyl ester
- 4,16α-[16α-18F]Difluoro-11β-methoxyestradiol
- 4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-1,3 pyrimidino)-p-[18F]fluorobenzamido]ethylpiperazine
- 4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine
- 4-(2-(4-(4-[18F]Fluoro-butyl)-phenyl)ethoxy) quinazoline
- 4-(3-((5-(2-[18F]Fluoroethoxy)pyridine-2-yl)oxy)benzylidene)-N-(pyridazin-3-yl)piperidine-1-carboxamide
- 4-[18F]Fluoro-2-D-methyl-3-mercaptopropanoyl-L-proline
- 4-[18F]Fluorobenzenecarbohydrazide-methotrexate
- 4-[18F]Fluorobenzoyl-annexin V
- 4-[18F]Fluorobenzoyl-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- 4-[18F]Fluorobenzoyl-C2A domain of synaptotagmin I-glutathione-S-transferase
- 4-[18F]Fluorobenzoyl-endothelin-1
- 4-[18F]Fluorobenzoyl-knottin 2.5D
- 4-[18F]Fluorobenzoyl-NAVPNLRGDLQVLAQKVART
- 4-[18F]Fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH2
- 4-[18F]Fluorobenzoyl-rhenium-cyclized-Ac-D-Lys-[Cys3,4,10, D-Phe7, Arg11]α-MSH3-13
- 4-[18F]Fluorobenzoyl-T84.66 diabody
- 4-[18F]Fluorobenzoyl-ε-Lys1-c(KRGDe)MDDPGRNPHhCitGPAT
- 4-[18F]Fluorobenzyl-triphenylphosphonium
- 4-[18F]Fluoro-l-m-tyrosine
- 4-[18F]Fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide
- 4-[18F]Fluoropaclitaxel
- 4-[5-(4-[18F]Fluoro-phenyl)-[1,3,4]oxadiazol-2-yl]-1,4-diaza-bicyclo[3.2.2]nonane
- 4-Bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole
- 5-(2-[18F]Fluoroethoxy)-L-tryphan
- 5-(5-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylbenzenamine
- 5-(5-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylpyridin-2-amine
- 5-[(E)-2-(4-[18F]Fluorophenyl)ethenyl]-1,3-benzenediol
- 5-[18F]Fluoro-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-oxazolo[5,4-b]pyridine
- 5-3’-[18F]Fluoropropyl-3-[2-((S)-pyrrolidinyl)methoxy]pyridine
- 6-(2-[18F]Fluoroethoxy)-2-[2-(4-methylaminophenyl)ethenyl]benzoxazole
- 6-(3'-[18F]Fluoropropyl)-2-(4'-dimethylamino)phenylimidazol[1,2-α]pyridine
- 6-[1-(2-[18F]Fluoro-3-pyridyl)-5-methyl-1H-1,2,3-triazol-4-yl]quinoline
- 6-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine
- 6-[18F]Fluorodopamine
- 6-[18F]Fluoro-l-m-tyrosine
- 6-Deoxy-6-[18F]fluoro-D-fructose
- 6-Iodo-2-[4'-N-(2-[18F]fluoroethyl)methylamino]phenylimidazo[1,2-a]pyridine
- 6-O-(2-[18F]Fluoroethyl)-6-O-desmethyldiprenorphine
- 8-Cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine
- 9-(4-(2-[18F]Fluoroethyl)benzyl)-9-azabicyclo[3.3.1]nonan-3-yl-2-methoxy-5-methyl-phenylcarbamate
- 9-(4-[18F]Fluoro-3-hydroxymethylbutyl)guanine
- Ad5-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-sr39tk
- Al18F-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2
- Al18F-1,4,7-Triazacyclononane-1,4,7-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- anti-1-Amino-2-[18F]fluorocyclobutane-1-carboxylic acid
- anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
- CtPyPyIm-(R)H2Nγ-PyImPyPy-C3-18F
- Cyclo(-Arg-Gly-Asp-d-Phe-Lys(([18F]Fluoropropionyl)galacto-amino acid)-)
- Cys-Arg-Pro-Pro-Arg-[18F]fluorodipalmitin-liposomes
- Fluoro-pegylated (1E,4E)-1-(4-(dimethylamino)phenyl)-5-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one
- ImPyβImPyβImβ-C3-18F
- L-3,4-Dihydroxy-6-[18F]fluorophenylalanine
- L- and D-S-(3-[18F]fluoropropyl)homocysteine
- m-Cyano-p-[18F]fluorohippurate
- Methyl 2-(2-[18F]fluoro-4-nitrobenzamido)-3-methylbutanoate
- Methyl 2-(2-[18F]fluoro-4-nitrobenzamido)-3- methylbutanoic acid
- Methyl ester of 1-O-(4-(2-[18F]fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-d-glucopyronuronate
- N-((E)-4-[18F]Fluorobut-2-en-1-yl)-2β-carbomethoxy-3β-(4'-fluorophenyl)nortropane
- N-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)ethyl))-N-(2-(6-[18F]fluoro)-pyridinyl)cyclohexanecarboxamide
- N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-4-[18F]-fluorobenzamide ([18F]FBEM) conjugated to EM3106B, an analog of glucagon-like peptide-1
- N-(2-(Diethylamino)ethyl)-6-[18F]fluoronicotinamide
- N-(2-Diethylaminoethyl)-4-[18F]fluorobenzamide for imaging melanoma
- N-(3-[18F]Fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane
- N-(4-(4-(2-(2-[18F]Fluoroethoxy)phenyl)piperazine-1-yl)butyl)-4-(3-thienyl)benzamide
- N-(4-[18F]Fluoro-benzoyl)-N'-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine
- N-(4-[18F]Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide
- N-(6-[18F]Fluoro-4-phenoxypyridin-3-yl)-N-(2-methoxybenzyl)acetamide
- N-[18F]Fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline
- N-[18F]Fluoroethylpiperidin-4ylmethyl acetate
- N-[2-(3-cyanophenyl)-3-(4-(2-[18F]fluorethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-Cys-ZEGFR:1907
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid dimeric peptide
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid peptide
- N-[2-[N-Ethyl-N-[2-(2-[18F]fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide
- N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine
- N-{2-[4-(2-Methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4-[18F]-fluoromethylcyclohexane)carboxamide
- N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged epidermal growth factor
- N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged on the C- or N-terminal of exendin-4
- N-4'-[18F]Fluorobenzylpiperidin-4yl-(2-fluorophenyl)acetamide
- N-4-[18F]Fluorobenzoyl-c(RGDyK)
- N-4-[18F]Fluorobenzoyl-c[(RGDyK)]2
- N-4-[18F]Fluorobut-2-yn-1-yl-2β-carbomethoxy-3β-phenyltropane
- N-Acetyl-N-(2-[18F]fluoroethoxybenzyl)-2-phenoxy-5-pyridinamine
- N-Benzyl-N-ethyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide
- N-Benzyl-N-methyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide
- O-(2-[18F]Fluoroethyl)-L-tyrosine
- O-(3-[18F]Fluoropropyl)-L-tyrosine
- p-(2-[18F]Fluoroethyl)-l-phenylalanine
- P2,P3-[18F]Monofluoromethylene diadenosine-5’,5’’’-P1,P4-tetraphosphate
- Para-[18F]-fluorohippurate
- PEGylated 4-[18F]fluorobenzoyl-NAVPNLRGDLQVLAQKVART
- Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-[18F]fluorobenzoyl-Lys-Lys-tetramethylrhodamine
- syn-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
- Trans-1,2,3,5,6,10b-hexahydro-6-[4-([18F]fluoroethylthio)-phenyl]pyrrolo-[2,1-a]-isoquinoline
- Trans-4-(N-Methylamino)-4´-{2-[2-(2-[18F]fluoro-ethoxy)-ethoxy]-ethoxy}-stilbene
- 44Sc
- 60,61,62,64, 67Cu
- 64Cu
- [64Cu](1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]-eicosane-1,8-diamine)-anti-GD2 monoclonal antibody
- [64Cu]-1,4,7,10-Tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid conjugated knottin 2.5D
- [64Cu]-1,4,7,10-Tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid conjugated knottin 2.5F
- 64Cu-[Ac-NIe-Asp-His-d-Phe-Arg-Trp-Gly-Lys(1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid)-NH2]
- 64Cu-[cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys(PEG-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid)-NH2]
- 64Cu-{N-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine}
- 64Cu-1,4,7,10-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 64Cu-1,4,7,10-Tetraazacyclodecane-N,N',N'',N'''-tetraacetic acid-vascular endothelial growth factor
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-CD105 TRC105 chimeric monoclonal antibody
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Asp-Gly-Glu-Ala
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-cyclo(CGNSNPKSC)
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-epidermal growth factor receptor-binding fibronectin domain E13.4.3'
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ser-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-ZEGFR:1907
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidethylacetamide-Ac-Cys-ZEGFR:1907
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-Tris-acetic acid-10-maleimidoethylacetamide-ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTG
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(N-ethylmaleimide amide)-dimeric (ZHER2:477)2
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(N-ethylmaleimide amide)-monomeric ZHER2:477
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-anti-prostate-specific membrane antigen 3/A12 monoclonal antibody
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-D-Ser-D-Arg-Tyr-Leu-Trp-Ser
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-d-Ser-d-Arg-Tyr-Leu-Trp-Ser-NH2 (AE105-NH2)
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cetuximab
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-C-type atrial natriuretic factor
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid- cyclic arginine-glycine-aspartic acid peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E(E{E[c(RGDyK)]2}2)2 peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDfK)]2}2
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDyK)]2}2
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HB22.7
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-interleukin-18-binding protein-Fc
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-panitumumab
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-p-benzyl-NH-hu14.18K322A
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated cyclic arginine-glycine-aspartic acid peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated dimeric cyclic arginine-glycine-aspartic acid peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol 12 anti–tumor-associated glycoprotein 72 diabody
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol 27 anti–tumor-associated glycoprotein 72 diabody
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene-glycol-single-walled nanotube-c(RGDyK)
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-vascular endothelial growth factor-121(D63AE64AE67A)
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid agouti-related protein-7C
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Tyr-Lys)
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-ALT-836
- 64Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14]
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetate-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-6-aminohexanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-9-aminonanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-c(RGDyK)-Glu-6-aminohexanoic acid-bombesin[7-14]NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-para-aminobenzoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,8,11-Tetraazacyclotetradecane-N,N',N",N"'-tetraacetic acid-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH)
- 64Cu-1,4,8,11-Tetraazacyclotetradecane-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclic-arginine-glycine-aspartic acid peptide
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH)
- 64Cu-4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-LLP2A
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-Phe(4-NO2)-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2
- 64Cu-Anti-human integrin αvβ3 monoclonal antibody
- 64Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu
- 64Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- 64Cu-Diethylenetriamine pentaacetic acid-NH-CO-CH2-S-CH2-Phe-Pro-Arg-CH2-prothrombin
- 64Cu-DOTA-[Pro1,Tyr4]-Bombesin[1-14]
- 64Cu-DOTA hu4D5v8 (scFv-CH2-CH3)2
- 64Cu-Labeled, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-chelated, and cysteine-modified anti-activated leukocyte cell adhesion molecule diabody
- 64Cu-Labeled 1,1’-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}
- 64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 64Cu-Labeled 1,4,7,10-Tetraazacyclododedane-N,N’,N’’,N’’’-tetraacetic acid–conjugated vascular endothelial growth factor A isoform 121-gelonin fusion protein
- 64Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys40-Exendin-4
- 64Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino)methyl)benzoic acid (AmBaSar)
- 64Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino)methyl)benzoic acid (AmBaSar) conjugated to cyclic arginine-glycine-aspartic acid (RGD) peptide
- 64Cu-Labeled anti-c-kit monoclonal antibody 12A8 Fab fragment
- 64Cu-Labeled bis-1,4,7,10-tetraazacyclododecane-N,N',N,N'-tetraacetic acid conjugated hypericin
- 64Cu-Labeled cysteine–tagged dimeric epidermal growth factor
- 64Cu-Labeled cysteine–tagged epidermal growth factor
- 64Cu-Labeled DOTA conjugated anti-epithelial membrane protein 2 minibody KS83
- 64Cu-Labeled DOTA-conjugated rituximab, a chimeric murine/human anti-CD20 monoclonal antibody
- 64Cu-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2)
- 64Cu-Labeled l-histidine
- 64Cu-Labeled Lys40(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid)NH2–conjugated exendin-4
- 64Cu-Labeled Oxo-DO3A-conjugated trastuzumab and PCTA-conjugated trastuzumab
- 64Cu-Labeled PEGylated nano-graphene oxide (GO) covalently linked to NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody TRC105
- 64Cu-N,N'-Bis(S-benzoyl-thioglycoloyl)diaminopropanoate-KRAS-PNA-d(Cys-Ser-Lys-Cys)
- 64Cu-Polyethylenimine
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-conatumumab
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-MEDI-522
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-TNYLFSPNGPIARAW (TNYL-RAW)
- 64Cu-Z-E-(1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo(6,6,6)eicosane)-aminohexanoyl-Asp-Gly-Glu-Ala
- Copper 1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-octreotide
- HSDAVFTDNYTKLRKQ-NIe-AVKK-(3-OCH3,4-OH)-FLNSSV-GABA-L-(Dap-(BMA)2)-64Cu
- NR-LU-10/streptavidin-copper 64-(1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid)-biotin
- 66Ga
- 68Ga
- 67/68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-1,2-diaminoethane-γ-folate
- 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11)
- 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-aminohexanoic acid-Lys40-exendin-4
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Epidermal growth factor
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Gly-Gly-Gly-Gly-Lys-Gly-Gly-Gly-Gly
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HER2-specific Affibody ZHER2:2891
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Lys40-exendin-3
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-synthetic HER2 specific Affibody ZHER2:342-pep2
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-5,8-dideazfolic acid (P3238)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-folate (P3246)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Asp-cyclohexylalanine-Phe-d-Ser-d-Arg-Tyr-Leu-Trp-Ser-NH2 (AE105-NH2)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-2-nitroimidazole-N-ethylamine
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDyK)-S-S-CPLHSpT
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-vascular endothelial growth factor-121
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[15-amino-4,7,10,13-tetraoxapentadecanoic acid-c(Arg-Gly-Asp-D-Phe-Lys)]2
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[c(Arg-Gly-Asp-D-Tyr-Lys)]2
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[Gly-Gly-Gly-c(Arg-Gly-Asp-D-Phe-Lys)]2
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14]
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-isothiocyanatobenzyl-c(Arg-Gly-Asp-d-Tyr-Lys)
- 68Ga-1,4,7-Triazacyclononane-1,4-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 68Ga-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 68Ga-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12
- 68Ga-DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
- 68Ga-Glutamate peptide-3 aminoethyl estradiol
- 68Ga-Isothiocyanatobenzyl-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine
- 68Ga-Labeled (1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid)-1-NaI3-octreotide
- 68Ga-Labeled (4-{[(bis(phosphonomethyl))carbamoyl]methyl}-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetic acid (BPAMD)
- 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys))
- 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 68Ga-Labeled 2-[3-(1-carboxy-5-{7-[5-carboxy-5-(3-phenyl-2-{3-phenyl-2-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]propionylamino}propionylamino)pentylcarbamoyl]heptanoylamino}pentyl)ureido]pentanedioic acid
- 68Ga-Labeled 2-[4,7-di(carboxymethyl)-1,4,7-triazonan-1-yl]-5-[(4-hydroxy-4,4-diphosphonobutyl)amino]-5-oxopentanoic acid (NOTA-bisphosphonate (BP))
- 68Ga-Labeled 2-{3-[5-(7-{1-benzyloxycarbonyl-5-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]pentylcarbamoyl}-heptanoylamino)-1-carboxypentyl]ureido}pentanedioic acid
- 68Ga-Labeled alanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid
- 68Ga-Labeled anti-EpCAM diabody against epithelial cell adhesion molecule
- 68Ga-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative
- 68Ga-Labeled homoalanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid
- 68Ga-Labeled NODAGA-conjugated ghrelin receptor agonists and inverse agonists
- 68Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
- 68Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7-triazacyclononane-1,4,7-triacetic acid
- 68Ga-N,N’-bis[2-Hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N’-diacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2}2
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 68Ga-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
- 68Ga-Trastuzumab F(ab’) fragment
- Gallium-68-dotamaleimide-Cys165-annexin A5
- Gallium-68-dotamaleimide-Cys2-annexin A5
- Gly-Ala-Cys-Leu-Arg-Ser-Gly-Arg-Gly-Cys-Gly-(PEG)3-DOTA-68Ga
- 74As
- 76Br
- 86Y
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-cetuximab
- 86Y-CHX-A''-diethylenetriamine pentaacetic acid-panitumumab
- 86Y-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 86Y-DOTA-[Pro1,Tyr4]-Bombesin[1-14]
- 86Y-DOTA-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 89Zr
- 89Zr-Desferrioxamine-anti-CD105 TRC105 chimeric monoclonal antibody
- 89Zr-Desferrioxamine-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody
- 89Zr-Desferrioxamine B-7E11 anti-prostate-specific membrane antigen monoclonal antibody
- 89Zr-Desferrioxamine B-J591 anti-prostate-specific membrane antigen monoclonal antibody
- 89Zr-Desferrioxamine B-Transferrin
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-hepatocyte growth factor nanobody 1E2 fused to albumin-binding nanobody Alb8
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-hepatocyte growth factor receptor 1-armed antibody onartuzumab
- 89Zr-Labeled fresolimumab (human anti-transforming growth factor-β monoclonal antibody)
- 89Zr-Labeled N-succinyldesferrioxamine-ranibizumab
- 89Zr-Labeled N-suc-desferrioxamine-conjugated anti-carbonic anhydrase IX chimeric monoclonal antibody cG250-F(ab’)2 fragments
- 89Zr-Labeled p-isothiocyanatobenzyl-desferrioxamine B (Df-Bz-NCS)–conjugated panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor
- 89Zr-Labeled trastuzumab, a humanized monoclonal antibody against epidermal growth factor receptor 2
- 89Zr-N-Succinyldesferal-anti-CD44v6 chimeric monoclonal antibody U36
- 89Zr-N-Succinyldesferal-chimeric monoclonal antibody G250
- 89Zr-N-Succinyldesferal-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507
- 89Zr-N-Succinyldesferrioxamine-bevacizumab
- 89Zr-N-Succinyldesferrioxamine-DN30
- 11C
- SPECT
- 111In
- [111In]5-[(3aR,6S,6aS)-2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid
- [111In]-DOTA-Aminohexanoyl-[D-Phe6,Leu-NHCH2CH2CH313,desMet14] BBN[6-14]
- [111In]-Ethylenedicysteine-murine anti-phosphotyrosine antibody
- [111In]Labeled-(NAc-dD-CHA-F-dS-dR-Y-L-W-S-βAla)2-K-K(DOTA)
- [111In]-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-heat-stable human Escherichia coli enterotoxin
- [111In]-Labeled chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX
- [111In]-Labeled divalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX
- [111In]-Labeled monovalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX
- [111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Pro1,Tyr4]Bombesin
- [111In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-10-maleimidoethylacetamide-Cys61]-Affibody ZHER2:2395
- [111In-Diethylenetriamine pentaacetic acid-ACMpip5,Tha6,βAla11,Tha13,NIe14]bombesin(5-14)
- [111In-Diethylenetriaminepentaacetic acid-Pro1,Tyr4]bombesin
- 111In/125/131I-Labeled anti-mucin-1 murine, chimeric or humanized antibody hPAM4
- 111In/125I/99mTc-Labeled N-terminus tri-(histidine-glutamate) (HE)3-tagged and N- or C-terminus hexahistidine (H6)-tagged anti-epidermal growth factor receptor Affibody ZHER2:342-C
- 111In/86Y-Labeled F(ab')2 fragment of panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor
- 111In-(1-isothiocyanatobenzyl-3-methyldiethylenetriaminepentaaetic acid)-anti–TAG-72 humanized CH2 domain-deleted antibody
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ac-RWQPCPAESWT-Cha-CWDPGGGK-NH2 (FibPep)
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-insulin-like growth factor 1 receptor Affibody ZIGF1R:4551
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-L-homoalanine
- 111In-1,4,7,10-tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide-Affibody ZHER2:2395-Cys
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-AB.Fab4D5
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid- Affibody ZHER2:342-pep2
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cyclo(D-diaminobutyric acid-Arg-Phe-Phe-D-Trp-Lys-Thr-Phe)
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-LLP2A
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 diabody
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 minibody
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin
- 111In-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-NDECELCVNVACTGCL
- 111In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2
- 111In-2-(4,7,10-Tris(carboxymethyl)-1,4,7,10-tetracyclododecan-1-yl)pentanedioic acid-Trastuzumab
- 111In-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine-N,N,N´,N´´,N´´-pentaacetic acid-trastuzumab
- 111In-Anti-CD105 MJ7/18 monoclonal antibody
- 111In-Benzyl-diethylenetriamine pentaacetic acid-AMB8LK
- 111In-Benzyl-diethylenetriaminepentaacetic acid-ZHER2:342
- 111In-Benzyl-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-ZHER2:342
- 111In-BZ-Diethylenetriaminepentaacetic acid-ZEGFR:1907
- 111In-Capromab pendetide
- 111In-CHX-A''-DTPA-anti-mindin/RG-1 monoclonal antibody 19G9
- 111In-CHX-A”-diethylenepentaacetic acid-Affibody ZHER2:2395-Cys
- 111In-CHX-A”-Diethylenetriamine pentaacetic acid-(ZEGFR:955)2
- 111In-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 111In conjugated to benzyl-diethylenetriaminepentaacetic acid-human epidermal growth factor
- 111In-Diethylenetriaminepentaacetic acid-2-(p-isothiocyanatobenzyl)-6-methyl-B3 monoclonal antibody
- 111In-Diethylenetriaminepentaacetic acid-2C5 monoclonal antibody
- 111In-Diethylenetriaminepentaacetic acid-aminohexanoic acid-Lys40-exendin-4
- 111In-Diethylenetriamine pentaacetic acid-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody
- 111In-Diethylenetriamine pentaacetic acid-Anti-ligand–induced binding sites (LIBS) single-chain (scFv) antibody
- 111In-Diethylenetriamine pentaacetic acid-bevacizumab
- 111In-Diethylenetriaminepentaacetic acid-cyclo(CTTHWGFTLC)
- 111In-Diethylenetriamine pentaacetic acid-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507
- 111In-Diethylenetriamine pentaacetic acid-human epidermal growth factor
- 111In-Diethylenetriamine pentaacetic acid-IC2 rat monoclonal autoantibody to pancreatic β-cell surface antigen
- 111In-Diethylenetriaminepentaacetic acid-Lys40-exendin-3
- 111In-Diethylenetriamine pentaacetic acid-NAVPNLRGDLQVLAQKVART
- 111In-Diethylenetriamine pentaacetic acid-pertuzumab
- 111In-Diethylenetriaminepentaacetic acid-polyethylene glycol-annexin V
- 111In-Diethylenetriamine pentaacetic acid-QKYGNQWAVGHLM-NH2
- 111In-Diethylenetriamine pentaacetic acid-single-walled nanotubes
- 111In-Diethylenetriaminepentaacetic acid-trastuzumab
- 111Indium-diethylenetriaminepentaacetic acid-d-phenylalanine-octreotide
- 111Indium-diethylenetriaminepentaacetic acid-folate
- 111In-DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
- 111In-DOTA-Gly-benzoyl-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
- 111In-DOTA-Re(Cys3,4,10,d-Phe7,Arg11)αMSH3-13
- 111In-DPC11870
- 111In-DTPA-Poly(ethylene glycol)-anti-epidermal growth factor receptor antibody C225
- 111In-Ibritumomab tiuxetan
- 111In-Labeled (7S)-26-(4-((1-((1-carboxy-5-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)pentyl)amino)-1-oxo-6-(1-((7S)-1,3,7,22-tetracarboxy-5,13,20-trioxo-4,6,12,21-tetraazahexacosan-26-yl)-1H-1,2,3-triazole-4-carboxamido)hexan-2-yl)carbamoyl)-1H-1,2,3-triazol-5-yl)-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated dimeric [Tyr3]octreotide
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated monomeric [Tyr3]octreotide
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-d-Tyr-d-Lys(HSG)-d-Glu-d-Lys(HSG)-NH2 (IMP-288)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N’,N”,N’”-tetraacetic acid-GSC(succinimidopropionyl-EAYGWNleDF-NH2)-EAYGWNleDF-NH2
- 111In-Labeled Ac-Phe-Lys(DTPA)-Tyr-Lys(DTPA)-NH2 (IMP-156)
- 111In-Labeled affibody ABY-025 targeting epidermal growth factor receptor 2
- 111In-Labeled anti-CD44v6 chimeric monoclonal antibody U36
- 111In-Labeled anti-epidermal growth factor receptor Affibody PEP09239
- 111In-Labeled anti-epidermal growth factor receptor human monoclonal antibody 048-006
- 111In-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 111In-Labeled CHX-A''-DTPA–conjugated MORAb-009, a chimeric monoclonal antibody directed against mesothelin
- 111In-Labeled CHX-A”-DTPA conjugated monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 111In-Labeled diethylenetriamine-pentaacetic acid-Ac-TZ14011
- 111In-Labeled DOTA-conjugated 6-aminohexanoic linker-containing variant of anti-epidermal growth factor receptor 2 Affibody ZHER2:342 (ABY-003)
- 111In-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative
- 111In-Labeled DTPA conjugated anti-c-kit monoclonal antibody 12A8 Fab fragment
- 111In-Labeled DTPA conjugated monoclonal antibody 12A8 that targets the c-kit receptor
- 111In-Labeled DTPA-conjugated Tat-linked anti-phosphorylated histone protein H2AX antibody
- 111In-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2)
- 111In-Labeled lexatumumab
- 111In-Labeled mapatumumab
- 111In-Labeled MLS128 anti-Tn murine monoclonal antibody
- 111In-Labeled panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor
- 111In-Labeled recombinant gelonin toxin-B lymphocyte stimulator protein fusion protein
- 111In-p-Benzyl isothiocyanate-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-14C5 monoclonal antibody
- 111In-Streptavidin-biotinylated α-melanocyte-stimulating hormone 2.0 bacteriophage
- 111In-TA138
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-c(D-Cys-Phe-Tyr-D-AgI8(Me,2-naphthoyl)-Lys-Thr-Phe-Cys)-OH
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-MEDI-522
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Phe(4-NO2)-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-(GSG)-ANTPCGPYTHDCPVKR
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Asp–Tyr(SO3H)–Met–Gly–Trp–Met–Asp–Phe–NH2
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid- d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-dihistidine-norleucine peptide analog
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-HHEAYGWMDF-NH2 peptide
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-HHHHHH-EAYGWMDF-NH2 peptide
- 111In-Tetrameric Plectin-1 targeting peptide (4(βAKTLLPTP-GGS(PEG5000))KKK-111In-DOTA-βA-NH2)
- 111In-Trastuzumab Fab
- 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-(SCN-Bz-DOTA-111In)-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine
- Anti-mouse monoclonal antibody immunoglobulin G conjugated to GRKKRRQRRRPPQGYG-diethylenetriamine pentaacetic acid-[111In]
- Biotinylated anti-Tn MLS128 monoclonal antibody-streptavidin-111In-DTPA-biotin
- Lys-cys-cys-tyr-ser-leu-(gly-ser-gly)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-111In
- Single-walled carbon nanotubes-111In-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-rituximab
- TA138-conjugated 111In nanoparticles
- 123I
- (1-Butyl-4-piperidinylmethyl)-8-amino-7-[123I]iodo-1,4-benzodioxan-5-carboxylate
- [123I]-2-Iodo-2-amino-3-phenylpropanoic acid
- [123I]Iomazenil
- [123I]Vascular endothelial growth factor
- [123I]-β-Methyl iodophenyl-pentadecanoic acid
- 1-(2,4-Dichlorophenyl)-5-(4-[123I]iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid N',N'-dimethyl-hydrazide
- 1(trans-[123I]Iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine
- 123/131I-Fab and F(ab')2 fragments of anti-integrin αvβ5 monoclonal antibody 14C5
- 123I-Annexin V
- 123I-Anti-vascular cell adhesion molecule monoclonal antibody 5F10
- 123I-Arg-Glu-Asn-Leu-Arg-Ile-Ala-Leu-Arg-Tyr
- 123I-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein
- 123I-Interleukin-2
- 123I-Labeled (S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl) ureido)pentyl)ureido)pentanedoic acid
- 123I-Labeled (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedoic acid
- 2-(2-(4-(4-[123I]Iodobenzyl)piperazin-1-yl)-2-oxoethyl)isoindoline-1,3-dione
- 2β-Carbomethoxy-3β-(4´-((Z)-2-[123I]iodoethenyl)phenyl)nortropane
- 5-[123I]Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine
- 6-Chloro-2-(4'-[123I]iodophenyl)-3-(N,N-diethyl)imidazo[1,2-a]pyridine-3-acetamide
- 7-(2-(4-(2-Fluoro-4-[123I]iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
- 8-[123I]Iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid
- Mono-[123I]Iodohypericin
- Mono-[123I]iodohypericine monocarboxylic acid
- N-(2-(Diethylamino)ethyl)-5-[123I]iodonicotinamide
- N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane
- N-(Morpholin-4-yl)-5-(4-[123I]iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide
- 123I,125I
- [123I/125I]6-Iodo-2-(4´-dimethylamino)-phenyl-imidazo[1,2-a]pyridine
- 125I-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 125I-Labeled monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-[123I]iodophenylamine
- Radioiodinated N-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide dihydrochloride salt
- 123I, 131I
- 123I/125I/131I
- 125I
- (2S,αS)-2-(α-(2-[125I]Iodophenoxy)benzyl)morpholine
- [125I](E)-N-1-(3'-iodoallyl)-N'-4-(3'',4''-dimethoxyphenethyl)-piperazine
- [125I]2-Iodo-N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide
- [125I]Anti-claudin 4 monoclonal antibody
- [125I]Anti-prostate stem cell antigen antibody
- [125I]-Labeled monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [125I]N-(4-Dipropylaminobutyl)-4-iodobenzamide
- [125I]N-[2-[N-Ethyl-N-[2-(2-fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide dihydrochloride salt
- 125I-Anti-malondialdehyde-modified low-density lipoprotein monoclonal antibody
- 125I-Hydroxylated-single-walled nanotubes
- 125I-Labeled anti-epidermal growth factor receptor human Fab antibody fragment
- 125I-Labeled anti-mucin 1 bispecific antibody bsPAM4
- 125I-Labeled heparin-binding peptides that target heparan sulfate proteoglycans for the in vivo imaging of peripheral amyloidosis
- 125I Labeled-mesenchymal-epithelial transition factor binding peptide
- 125I-Labeled mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid
- 125I-Labeled mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly
- 125I-Labeled monoclonal antibody, mAb RM2, targeting the RM2 antigen
- 125I-Labeled monoclonal antibody PSA30
- 125I-Labeled mouse anti-human carbonic anhydrase IX monoclonal antibody
- 125I-Labeled murine anti-CD20 antigen monoclonal antibody NuB2 conjugated to one or three octaarginine (maleimide-(6-aminocaproic acid)2-(D-Arg)8-(D-Tyr)) peptide chains
- 125I-Labeled single-chain monoclonal antibody, NS4F5, that targets the GlcNS6S-IdoA2S motif of heparan sulfate proteoglycans for the in vivo imaging of peripheral amyloidosis
- 125I-Labeled trivalent, bispecific monoclonal antibody construct TF10 that targets mucin-1 and is reactive against a histamine-succinyl-glycine hapten IMP-288
- 125I-Radioiodinated tyrosine-folate and tyrosine-click-folate
- 125I-Single-chain antibody B1 targeting a pancreatic β-cell surface antigen
- 125I-Single-chain antibody B5 targeting a pancreatic β-cell surface antigen
- 125I-T84.66 scFv-human serum albumin
- 125I-Vascular endothelial growth factor-121
- 2-(4'-Dimethylaminophenyl)-6-[125I]iodobenzothiazole
- 2-{[4-(4-[125I]Iodobenzyl)piperidin-1-yl]methyl}benzimidazol-5-ol
- 3-(4-Hydroxy-3-[125I]iodophenyl)propionate-exendin(9-39)
- Biotinylated anti-Tn MLS128 monoclonal antibody-125I-streptavidin
- Fluorinated and iodinated (Z)-2-(4-(2-fluoroethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one
- N,N-Diethyl-2-(2-(3-[125I]iodo-4-methyoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide
- N-{2-[4-(4-[125I]Iodobenzyl)-piperidin-1-ylmethyl]benzoimidazol-5-yl}-methanesulfonamide
- N1,N1-diethyl-N4-(7-[125I]iodoquinolin-4-yl)pentane-1,4-diamine
- Radioiodinated (1E,4E)-1-(4-aminophenyl)-5-(4-iodophenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-iodophenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one
- Radioiodinated (Z)-2-(4-(2-hydroxyethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one
- Radioiodinated anti-CD105 MAEND3 monoclonal antibody
- Radioiodinated anti–TAG-72 CC49 Fab’ antibody fragment
- Radioiodinated-anti–TAG-72 covalently linked CC49 divalent single-chain Fv antibody
- Radiolabeled (hetero)aromatic analogs of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and therapy of melanoma
- 125I/131I
- Radioiodinated anti-TAG-72 CC49 tetravalent single-chain Fv antibody
- Radioiodinated anti-TAG-72 humanized CH2 domain-deleted antibody
- Radioiodinated anti–TAG-72 non-covalently linked CC49 divalent single-chain Fv antibody
- Radioiodinated humanized monoclonal antibody A33
- Radioiodinated MLS128 anti-Tn murine monoclonal antibody
- 125mTe
- 131I
- [131I]N-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-(2-napthyl)propanamide
- 131I-Chlorotoxin
- 131I-Human recombinant anti-ED-B fibronectin antibody small immunoprotein
- 131I-Labeled [Z]-2-[4-(1,2-diphenyl-1-di-butenyl)-phenoxy]-N,N-dimethylethanamine
- 131I-Labeled anti-α folate receptor human antibody fragment AFRA-DMF5.3 dimer
- 131I-Labeled recombinant anti-glycoprotein A33 antibody single chain variable fragment fused to cytosine deaminase
- 131I-NP-4 anti-CEA monoclonal antibody
- 131I-Tositumomab
- 3'-(E)-(2-[123/131I]Iodovinyl)uridine
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[131I]iodo-5-methoxybenzyl)acetamide
- N(ε)-(3-[131I]Iodobenzoyl)-Lys5-N(α)-maleimido-Gly1-GEEEK-anti-HER2 nanobody 5F7GGC
- R-2-[131I]Iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone
- Radioiodinated anti-DNA-histone 1 complex chimeric tumor necrosis therapy (TNT) monoclonal antibody 1
- 131I, 123I, 125I
- 131I, 125I
- 170Tm
- 177Lu
- [177Lu]-Labeled (S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (C-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [177Lu]-Labeled [(R)-2-amino-3-(4-isothiocyanatophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid (CHX-A″-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [177Lu]-Labeled 2-(4-isothiocyanatobenzyl)-6-methyldiethylene-triaminepentaacetic acid (1B4M-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [177Lu]-Labeled α-(5-isothiocyanato-2-methoxyphenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (MeO-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- 177Lu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-ZEGFR:1907
- 177Lu-Benzyl-diethylenetriamine pentaacetic acid-anti-carbonic anhydrase IX small immunoprotein A3
- 177Lu-CHX-A''-DTPA-ABD-Affibody (ZHER2:342)2
- 177Lu-DOTA-Gly-4-aminobenzoyl-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 177Lu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys))
- 177Lu-Labeled aglycosylated anti-L1-CAM monoclonal antibody chCE7
- 177Lu-Labeled DOTA-conjugated AE105 peptide (Asp-Cha-Phe-(d)Ser-(d)Arg-Tyr-Leu-Trp-Ser-CONH2)
- 177Lu-Labeled ethylenediamine tetramethylene phosphonic acid
- 177Lu-Labeled h-R3 (nimotuzumab), a humanized monoclonal antibody targeting the external domain of the epidermal growth factor receptor
- 177Lu-Labeled humanized monoclonal antibody against human epidermal growth factor receptor 2
- 177Lu-Labeled methylene diphosphonate
- 177Lu-Labeled sodium pyrophosphate
- 186Re
- 188Re
- 211At
- 67Ga
- 67Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Gly-Glu-c[Lys-Nlc-Glu-His-d-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp]
- 67Ga labeled cyclic diethylenetriamine pentaacetic acid Insulin
- 67Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-3-{2-[2-(3-amino-propoxy)-ethoxy]-ethoxy}-propylamine-γ-folate
- 99mTc
- [2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2]oxo-[1R-exo-exo)])- [99mTc]-technetium
- [99mTc/90Y]-1,4,7,10 Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid phenylalanine derivative conjugated to anti-epidermal growth factor receptor antibody ior egf/r3
- [99mTc(CO)3]+-Labeled anti-epidermal growth factor receptor (HER2) affibody ZHER2:342 with a hexa-histidine tag (H6) on the C-terminal
- [99mTc(CO)3]+-Labeled anti-epidermal growth factor receptor (HER2) affibody ZHER2:342 with a hexa-histidine tag (H6) on the N-terminal
- [99mTc(CO)3]+-Labeled anti-epidermal growth factor receptor (HER2) affibody ZHER2:342 with a tri-(histidine-glutamate) peptide tag (HE)3 on the N-terminal
- [99mTc(N)(NS-Cys-Gly-CCK-8)(PNP3)]+
- [99mTc](CO)3N-(pyridin-2-yl-methyl)-N[2-(4-sulfamoylphenyl)-ethyl]aminoethyl acetate
- [99mTc]1,4,7,10-tetraazacyclododecane-N, N’, N’’, N’’’-tetraacetic acid-Phe-Lys-histamine-succinyl-Gly-D-Tyr-Lys- histamine-succinyl-Gly-thiosemicarbazonyl-glyoxyl-cysteine
- [99mTc]-1,4,7,10-Tetraazacyclododecane tetramethylenephosphonic acid
- [99mTc]4-Dithiocarbamato-N-benzylpiperidine
- [99mTc]-Acetyl-arg-arg-arg-arg-arg-cys-gly-cys-gly-gly-pro-leu-tyr-arg-arg-ile-ile-arg-arg-leu-leu-glu-ser-dermatan sulfate
- [99mTc]Anti-CD3 monoclonal antibody
- [99mTc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1‡1´)-sulfide with 3-[(mercaptoacetyl)amino]-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide
- [99mTc]-diethylenetriaminepentaacetic acid-galactosyl human serum albumin
- [99mTc]Epidermal growth factor receptor–specific nanobody
- [99mTc]Human telomerase reverse-transcriptase antisense mRNA oligonucleotide
- [99mTc]-Mercaptoacetyldiglycyl-1,5-diaminopentylene hypericincarboxamide
- [99mTc]-Pentavalent dimercaptosuccinic acid
- [99mTc]Vasoactive intestinal peptide-aminobutyric acid-Gly-Gly-(D)-Ala-Gly
- [99mTc-Gly-Gly-Cys]-Ornithine-ornithine-ornithine-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- [99mTc-N40-1-bzlg0,D-Phe6,Leu-NHEt13,des-Met14]Bombesin(6–14)
- 99mTc/111In-Labeled DTPA-succinyl polylysine
- 99mTc/188Re-Labeled dipicolylamine-alendronate
- 99mTc-(3Z)-4-{4-[2-(Dimethylamino)ethoxy]phenyl}-3,4-diphenylbut-3-en-1-ylN,N-bis[2-(2,6-dioxomorpholin-4-yl)ethyl]glycinate
- 99mTc(CO)3-((S-Pyridin-2-ylmethyl)-Cys)-Nle-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2
- 99mTc(CO)3-Anti-carcinoembryonic antigen (CEA) humanized CEA5 graft nanobody
- 99mTc(CO)3-Anti-epidermal growth factor receptor nanobody 8B6
- 99mTc(CO)3-Anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5
- 99mTc(CO)3-Bipyridine-cyclo-(Arg-Gly-Asp-D-Tyr-Lys)
- 99mTc(CO)3-Pyrazolyl-cyclo(Arg-Gly-Asp-D-Tyr-Lys)
- 99mTc-(Hydrazinonicotinic acid-duramycin)(tricine)(TPPTS)
- 99mTc-(Hydrazinonicotinic acid-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2)(tricine)(TPPTS)
- 99mTc-(NαHis)Ac-(Arg-N-CH3)-Arg-Pro-(dimethyl-Tyr)-(tertary-Leu)-Leu
- 99mTc-(RR,SS)-4,8-diaza-3,6,6,9-tetramethylundecane-2,10-dione bisoxime
- 99mTc(v)O-Gly-Gly-Cys-Orn-Orn-Orn-Bombesin[2-14]
- 99mTc-[Ac-CCEHdFRWCKPV-NH2]
- 99mTc-[Cys3,4,10,d-Phe7,Arg11]α-MSH3-13
- 99mTc-1,4,7-Tris(carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane-Folate
- 99mTc-2-[Bis-(2-mercaptoethyl)]aminoethanethiol-4-isocyano-N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]butanamide
- 99mTc-2-Methoxyisobutylisonitrile
- 99mTc-Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-3-iodo-Tyr-Thr-Leu-Leu-Lys-Gly-NC100194
- 99mTc-Ac-Lys(DTPA)-Tyr-Lys(DTPA)-Lys(thiosemicarbazonyl-glyoxyl-cysteinyl-)-NH2 (IMP-192)
- 99mTc-Affibody ZHER2:2395-Cys
- 99mTc-Anti-CD105 E9 monoclonal antibody
- 99mTc-Anti-ED-B fibronectin L19-(Gy)3-Cys-Ala scFv antibody fragment
- 99mTc-Anti-ED-B fibronectin single-chain antibody fragment L19-Hi20
- 99mTc-Anti-ED-B fibronectin single-chain antibody fragment L19-His
- 99mTc- anti-EGFR monoclonal antibody h-R3
- 99mTc-Arcitumomab
- 99mTc-Bis-amino-bis-thiol-conjugated 6-(3-bromopropoxy)-2-(4-(dimethylamino)phenyl)-4H-chromen-4-one and (Z)-5-(3-bromopropoxy)-2-(4-(dimethylamino)benzylidene)benzofuran-3(2H)-one
- 99mTc-CCND1-PNA-IGF1 Chimeras
- 99mTc-Cys-Gly-Gly-Affibody ZHER2:342
- 99mTc-Diamine dioxime-Lys-Cys-Arg-Gly-Asp-Cyc-Phe-Cys-polyethylene glycol
- 99mTc-Diethylenetriaminepentaacetate-deoxyglucose
- 99mTc-Diethylenetriamine pentaacetic acid–lactosyl human serum albumin
- 99mTc-Diethylenetriaminepentaacetic acid-mannosyl-dextran
- 99mTc-Diethylenetriamine pentaacetic acid superparamagnetic iron oxide nanoparticles conjugated with lactobionic acid
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinamide-[dGlu1]minigastrin
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-[dGlu1, desGlu2–6]minigastrin
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-cyclo(Arg-Gly-Asp-D-Try-Lys)
- 99mTc-ethylenediamine N,N’-diacetic acid/hydrazinonicotinamide-Tyr3-octreotide
- 99mTc-Ethylenedicysteine-C225
- 99mTc-Ethylenedicysteine-deoxyglucose
- 99mTc-Ethylenedicysteine-endostatin
- 99mTc-Ethylenedicysteine-folate
- 99mTc-Ethylenedicysteine-guanine
- 99mTc-Ethylenenediamine-N,N'-diacetic acid/hydrazinonicotinamide[Lys3]-bombesin
- 99mTc-Fucoidan, a polysaccharidic ligand of P-selectin
- 99mTc-Galactosyl-methylated chitosan
- 99mTc-Glucosamine-multiwall carbon nanotubes
- 99mTc-Glucosamino-Asp-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 99mTc-glutamate peptide 3-aminoethyl estradiol
- 99mTc-Gly-Gly-Cys-(Arg)3-bombesin(2-14)-NH2
- 99mTc-Hexamethylpropyleneamine oxime-blue-biotin-liposomes
- 99mTc-Hexamethylpropyleneamine oxime pH-sensitive liposomes
- 99mTc-Human β-defensin-3
- 99mTc-Hydrazinonicotinamide/tricine-eighteen-nucleotide RIα mRNA antisense small interfering oligoribonucleotides
- 99mTc-Hydrazinonicotinamide-aminohexanoic acid-Lys40-exendin-4
- 99mTc-Hydrazinonicotinamide-annexin V
- 99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 divalent single-chain Fv monoclonal antibody
- 99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 tetravalent single-chain Fv monoclonal antibody
- 99mTc-Hydrazinonicotinamide-chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101
- 99mTc-Hydrazinonicotinamide-epidermal growth factor
- 99mTc-Hydrazinonicotinamide-galactosyl-chitosan
- 99mTc-Hydrazinonicotinamide-interleukin-8
- 99mTc-Hydrazinonicotinic acid-bitistatin
- 99mTc-Hydrazinonicotinic acid-cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Phe-NH2
- 99mTc-Hydrazinonicotinic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
- 99mTc-Hydrazinonicotinic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2
- 99mTc-Hydrazinonicotinic acid-single-chain Cys-tagged vascular endothelial growth factor-121
- 99mTc-Hydrazinonicotinyl(tricine)(TPPTS)-Glu-c(RGDyK)-bombesin[7-14]NH2
- 99mTc-Interleukin-18-binding protein-Fc-interlukin-1 receptor antagonist
- 99mTc-Interleukin-2
- 99mTc-Labeled, PEGylated (NαHis)Ac-β3hLys-βAla-βAla-Gln7-Trp8-Ala9-Val10-Gly11-His12-Cha13-Nle14-NH2
- 99mTc-Labeled (1S,3S)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranoside
- 99mTc-labeled [N40,Pro1,Tyr4]bombesin
- 99mTc-Labeled 13,13’[oxybis[methylene(2,5-dioxo-1,3-pyrrolidinediyl)]]bis[N-(mercaptoacetyl)-D-tyrosyl-S-(3-aminopropyl)-L-cysteinylglycyl-L-α-aspartyl-L-cysteinylglycylglycyl-S-[(acetylamino)methyl]-L-cysteinylglycyl-S-[(acetylamino)methyl-L-cysteinylglycylglycyl-L-cysteinamide],cyclic(1→5),(1’→5’),-bis(sulfide)
- 99mTc-Labeled 1-hydroxy-2-(2-ethyl-4-methyl-1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid
- 99mTc-Labeled 1-hydroxy-2-(2-isopropyl-1H-imidazole-1-yl)ethylidene-1,1-bisphosphonic acid
- 99mTc-Labeled 1-hydroxy-3-(1H-imidazol-1-yl)propane-1,1-diyldiphosphonic acid (IPrDP)
- 99mTc-Labeled 5-amino-1,3-bis(ethylamine-(N,N-dimethyl diphosphonic acid)acetamido)benzene
- 99mTc-Labeled 6-hydrazinopyridine-3-carboxylic acid (HYNIC)–conjugated murine anti-MUC1 monoclonal antibody PR81
- 99mTc-Labeled 6-hydrazinopyridine-3-carboxylic acid conjugated to hydroxy-bisphosphonate
- 99mTc-Labeled acetylated dendrimer poly(amido)-amine generation 5-folic acid-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate
- 99mTc-Labeled acetylated dendrimer poly(amido)-amine generation 5-PEGylated folic acid-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate
- 99mTc-Labeled anti-carcinoembryonic antigen monoclonal antibody CL-58
- 99mTc-Labeled anti-macrophage mannose receptor (MMR; CD206) nanobody
- 99mTc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)2 fragments
- 99mTc-Labeled anti-receptor for advanced glycation endproducts polyclonal antibody F(ab’)2 fragments
- 99mTc-labeled anti-tumor necrosis factor-alpha monoclonal antibody
- 99mTc-Labeled citric acid-folate conjugate
- 99mTc-Labeled cysteine-tagged dimeric epidermal growth factor
- 99mTc-Labeled cysteine-tagged epidermal growth factor
- 99mTc-Labeled doxorubicin
- 99mTc-Labeled hydrazinonicotinamide-cysteine-annexin A5
- 99mTc-Labeled imine 6-(pyridine-2-methylimine)-4-[(3-bromophenyl)amino]quinazoline
- 99mTc-labeled ior-egf/r3 monoclonal antibody against epidermal growth factor receptor
- 99mTc-Labeled lexatumumab
- 99mTc-Labeled mannosylated dextran DCM20
- 99mTc-Labeled mapatumumab
- 99mTc-Labeled mercaptoacetylglycylglycylglycine conjugated to hydroxy-bisphosphonate
- 99mTc-Labeled murine IgM monoclonal antibody, fanolesomab, that targets the CD15 glycoprotein antigen
- 99mTc-Labeled N-(triethylammonium)-3-propyl-[15]ane-N5
- 99mTc-Labeled Nε49 mercaptoacetyl derivatives of affibody ZHER2:342 targeting the human epidermal growth factor receptor
- 99mTc-Labeled O-[3-(1,4,8,11-tetraazabicyclohexadecane)-propyl]-α-methyl tyrosine
- 99mTc-Labeled peptide derivative of folic acid
- 99mTc-Labeled poly(ethyleneglycol)–N-(N-(3-diphenylphosphinopropionyl)glycyl)-S-tritylcysteine (PEG-PN2S)-linked ubiquicidin (UBI)
- 99mTc-Labeled pyridyl benzofuran derivatives to target β-amyloid plaques
- 99mTc-Labeled rituximab, a chimeric murine/human anti-CD20 monoclonal antibody
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine d-galactose
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine d-glucose
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine n-acetylglucosamine
- 99mTc-Labeled succinimidyl-6-hydrazinonicotinate hydrochloride (SHNH)-conjugated visilizumab
- 99mTc-Labeled tetraethylenepentamine-folate
- 99mTc-Labeled trans-1,2-cyclohexyldinitrilo tetramethylene phosphonic acid
- 99mTc-Labeled tumor-associated glycoprotein 72 binding peptides A2-6 and A3-10
- 99mTc-Labeled tumor-associated glycoprotein 72 binding peptides G3-15 and T3-15
- 99mTc-Mercaptoacetyl-Glu-Glu-aptamer specific for tenascin-C
- 99mTc-Mercaptoacetyl-Glu-Glu-Glu-Affibody ZHER2:342
- 99mTc-Mercaptoacetyl-Gly-Gly-Gly-Affibody ZHER2:342
- 99mTc-Mercaptoacetyl-Gly-Gly-Gly-PAP-1
- 99mTc-Mercaptoacetyl-Ser-Ser-Ser-Affibody ZHER2:342
- 99mTc-Methyl diphosphonate
- 99mTc-Monocyte chemoattractant protein-1
- 99mTc-N,N'-Bis(S-benzoyl-thioglycoloyl)diamidopropanoyl-KRAS-PNA-d(Cys-Ser-Lys-Cys)
- 99mTc-N2S2-Tat(49-57)-Lys3-bombesin
- 99mTc-Nicotinic acid/tricine/hydrazinonicotinamide-nonsulfated cholecystokinin-8
- 99mTc-Nicotinic acid/tricine/hydrazinonicotinamide-sulfated cholecystokinin-8
- 99mTcO-N,N-Dimethylglycyl-l-lysinyl-l-cysteinylamide-8-amino-3,6-dioxaoctanoic-probestin
- 99mTc-pGlu-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2
- 99mTc-Regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4
- 99mTc-S-acetylmercaptoacetyltriserine-stromal-derived factor 1α
- 99mTc-succinimidyl-6-hydrazinopyridine-3-carboxylate-interleukin 12
- 99mTc-Tricarbonyl-His6-annexin A5
- 99mTc-Tricarbonyl-K-H-K-H-cholecystokinin 8
- 99mTc-Tricarbonyl–labeled aspartic-N-monoacetic acid (ASMA)
- 99mTc-Type II tumor necrosis receptor-Fc-interlukin-1 receptor antagonist fusion protein
- 99mTc-Ubiquicidin29-41
- 99mTc≡Nitrido(diphosphine)-Cys-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- Acetyl-lys-lys-lys-lys-lys-cys-gly-cys-gly-gly-pro-leu-tyr-lys-lys-ile-ile-lys-lys-leu-leu-glu-ser-heparin-[99mTc]
- N-[2-(N-(2-mercaptoethyl)) amino ethyl]-N-(2-mercaptoethyl)-3,5-dimethylacetamide amantadine-technetium
- Tricarbonyl[99mTc]technetium(I)-((S)-6-(8-(bis(pyridin-2-ylmethyl)amino)octanamido)-2-((S)-1-carboxy-3-phenylpropylamino)hexanoyl)pyrrolidine-2-carboxylic acid
- Tri-methoxy-tris-pyrazolyl-99mTc-(CO)3
- 111In
- Ultrasound
- Dye
- Gold
- ICG
- Microbubbles
- Abciximab microbubbles
- Air-filled, cross-linked, human serum albumin microcapsules
- Anti-ligand–induced binding sites (LIBS) single-chain antibody conjugated to microbubbles
- Anti-vascular cell adhesion molecule-1 monoclonal antibody M/K-2.7 microbubbles
- Buried cyclo(Arg-Gly-Tyr(Me)-Lys-Glu) microbubbles
- Magnetic microbubbles conjugated with anti-vascular cell adhesion molecule-1 monoclonal antibody 429
- Microbubble-conjugated vascular endothelial growth factor receptor 2 binding peptide
- Microbubble-conjugated vascular endothelial growth factor receptor 2 monoclonal antibody
- Microbubbles coated with antibody to intracellular adhesion molecule-1
- Microbubbles coated with antibody to mucosal addressin cellular adhesion molecule-1
- Microbubbles coated with anti-P-selectin antibody RB40.34
- Microbubbles coated with biotinylated rabbit anti-mouse endoglin monoclonal antibody
- Microbubbles coated with biotinylated rabbit anti-mouse vascular endothelial growth factor receptor 2 (VEGFR-2) monoclonal antibody
- Microbubbles coated with biotinylated rabbit anti-mouse αVβ3 integrin monoclonal antibody
- Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal antibody sc-13595
- Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5
- Microbubbles conjugated with cyclo(CGGRRLGGC)
- Microbubbles conjugated with knottin 2.5D
- Microbubbles conjugated with single-chain Cys-tagged vascular endothelial growth factor-121
- Microbubbles-echistatin
- Microbubbles with a disteroylphosphatidylcholine, disteroylphosphatidylethanolamine-polyethyleneglycol (PEG) 2000-pyridyldithio propionate-PEG 40 stearate shell conjugated to cyclic arginine-glycine-aspartic acid-d-tyrosine-lysine (cRGD) pentapeptide
- Perflexane-Lipid Microspheres
- Perflutren lipid microspheres
- Sonicated human serum microspheres
- Stabilized sulfur hexafluoride microbubbles
- Nanobubbles
- X-Ray, CT
- Au
- Bi
- Iodine
- (S)-N,N’-bis[2-hydroxy-1-(hydroxymethyl)-ethyl-2,4,6-triiodo-5-lactamidoisophthalamide
- 1,3-Bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol
- 5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
- Ethyl-3,5-bis(acetylamino)-2,4,6-triiodobenzoate nanoparticles
- Ioxilan carbonate particles
- Lipiodol-loaded poly(oxyethylene)-block-poly(oxypropylene)-block-poly(oxyethylene) triblock copolymers/polyethylene glycol-nanoparticles
- N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodoisophthalamide
- N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2,4,6-triiodoisophthalamide
- N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide
- Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate